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Abstract 
Methane produced from methanogenesis in archaea may be a promising source of 
renewable energy as methanogens are the primary producers of biogenic methane. 
However, methanogens are anaerobic and experience transient oxygen exposure in their 
environment, leading to degradation of proteins involved in methanogenesis pathways. 
Elucidating the oxidative stress response mechanisms in methanogens may lead to the 
development of more oxygen-tolerant strains with robust methanogenesis capabilities in 
bioreactors for production of methane as a renewable energy source. MsvR is a redox-
sensitive transcription regulator exclusively found in methanogens. It was initially 
identified in M. thermautotrophicus as a regulator of the fpaA-rlp-rub operon, which is 
implicated in the oxidative stress response. The MsvR homolog in M. acetivorans 
(MaMsvR) was found to have ten cysteine residues, three of which are conserved in 
MsvR from M. thermautotrophicus. This lead to the substitutional analysis of each 
cysteine in MaMsvR that implicated seven cysteines (C63, C89, C148, C175, C206, 
C232 and C240) in redox sensing and/or conformational change affecting MaMsvR 
binding to its promoter (Ma PmsvR). RNA-seq was utilized for preliminary analysis of the 
MaMsvR regulon and it was found that MaMsvR directly or indirectly regulates genes 
encoding function in methanogenesis, signal transduction, transcription regulation and 
various other cellular functions. The data suggests MaMsvR is involved in regulatory 
hierarchies that modulate central metabolism and that regulation may be redox-
dependent.
1 
Chapter 1: Introduction 
Climate change is one of the most important yet challenging issues facing 
humanity today. Greenhouse gases absorb heat emitted from the earth and trap it in the 
atmosphere. Since the industrial revolution, the amount of greenhouse gases emitted 
from human activity has drastically increased and is slowly warming the planet (1). The 
two most potent contributors to global warming are the greenhouse gases methane and 
carbon dioxide (CO2), with methane having a global warming potential that is 25 times 
greater than carbon dioxide over a timescale of 100 years because it is more efficient at 
absorbing radiation than CO2 (1, 2). Reducing these greenhouse gas emissions is 
imperative to mitigating the consequences of climate change. Methanogenic archaea are 
the primary source of biogenic methane produced from the metabolism of one-carbon 
compounds and/or CO2 and hydrogen in a process called methanogenesis (3).  
These methanogenic archaea, also referred to as methanogens, are anaerobic 
organisms that can only perform methanogenesis under anoxic conditions. Exposure of 
methanogens to oxygen leads to the generation of reactive oxygen species (ROS) such 
as hydrogen peroxide (H2O2) and superoxide that target and oxidize cellular 
components (4). These ROS can damage DNA, oxygen-sensitive proteins such as those 
involved in methanogenesis, and other molecules in the cell. Methanogens are 
transiently exposed to oxygen in their environment but can continue methanogenesis 
after oxidant exposure, which suggests they have mechanisms in place to protect 
oxygen-sensitive proteins from damage during oxidative stress (5). Understanding how 
methanogens combat oxidative stress is central to combating global warming by the 
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development of more oxygen-tolerant species in bioreactors for the production of 
methane as a renewable energy source. 
A promising lead to elucidating how methanogens survive oxidative stress came 
from the differential expression of the fpaA-rlp-rub operon in Methanothermobacter 
thermautotrophicus through microarray analysis (6). The operon includes genes 
encoding a flavoprotein (fpaA), rubrerythrin-like protein (rlp) and a rubredoxin (rub) 
and is located downstream of msvR, a gene that is divergently transcribed from the 
operon (7). The fpaA-rlp-rub operon was found to be upregulated along with genes 
encoding for thioredoxin (Trx) and thioredoxin reductase (TrxR) after hydrogen 
peroxide (H2O2) exposure. This indicates that M. thermautotrophicus utilizes these 
enzymes to protect intracellular molecules from oxidation by ROS instead of more 
common antioxidant enzymes like superoxide dismutase or catalase (7).  
The basal transcriptional machinery in Archaea is a simplistic version of the 
eukaryotic transcription system, although the gene regulatory mechanisms in Archaea 
are more similar to bacterial regulators (8-10). Archaeal transcriptional machinery 
consists of a transcription factor II B (TFB) homolog, a TATA-binding protein (TBP) 
and RNA polymerase (RNAP) that resembles RNAP II in eukaryotes (11, 12). The 
RNAP in Archaea have 11-13 subunits, depending on the species, and share a closer 
homology to eukaryotic RNAPII than to bacterial RNAP (13, 14). Archaeal 
transcription is initiated when TBP binds to the TATA box, a thymine and adenine-rich 
sequence located approximately 25 base pairs upstream of the transcriptional start site 
(15). TBP then recruits TFB to the promoter, where it binds to the purine-rich B-
3 
recognition element (BRE) located immediately upstream of the TATA box (16). 
RNAP is then recruited to the promoter to complete the pre-initiation complex (12).  
Although the archaeal basal transcriptional machinery is more similar to that in 
eukaryotes, the regulatory mechanisms and transcription regulators are more similar to 
bacterial regulators. In bacteria, a gene may be regulated by a single activator that binds 
upstream of the promoter region, or by a repressor that binds close to the promoter and 
directly blocks RNAP and transcription factors from binding to the promoter (17).  
Archaeal transcription regulators, which are predominantly repressors, function 
similarly to bacterial repressors and share the characteristic helix-turn-helix (HTH) 
domain that binds DNA. Archaeal repressors can either bind to the promoter to prevent 
recruitment of TFB and TBP to the pre-initiation complex or they can compete with 
RNAP for the transcriptional start site (10). Regulators that are involved in the oxidative 
stress response must be able to sense a redox shift within the cell. When ROS are 
present in the cell, a regulator senses the redox shift and either binds to its promoter 
region or releases itself from the DNA in order to activate or repress genes involved in 
the oxidative stress response. Redox sensing bacterial regulators such as OxyR, PerR 
and RexT have been studied more extensively than archaeal regulators and can provide 
insights into the redox-sensing mechanisms in archaeal regulators. 
Numerous studies have shown that cysteine residues play a major sensory role in 
redox-sensing transcription regulators (18-20). Cysteine residues contain thiol groups 
that can react with oxygen-containing compounds to form disulfide bonds (21, 22). 
Formation of these disulfide bonds can cause a conformation change in the protein that 
alters its ability to bind DNA (23). OxyR is a tetrameric transcription regulator that was 
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originally characterized in Escherichia coli (24). H2O2 oxidizes one cysteine residue in 
OxyR and causes it to quickly form an intramolecular disulfide bond with a second 
cysteine (25). The resulting conformational change allows OxyR to interact with RNAP 
to activate or repress expression of genes in the OxyR regulon, which includes 
antioxidant gene products that combat ROS (26). The OxyR regulon also includes genes 
encoding glutathione and glutathione reductase 1, which enzymatically deactivate OxyR 
by reducing the disulfides back to free thiols (25). This autoregulation ensures that 
OxyR is only activated during oxidative stress. 
RexT is a redox-sensing transcription regulator of the ArsR family that is 
involved in the oxidative stress response. It was first described in the cyanobacterium 
Anabaena sp. and was the first reported transcriptional regulator of the thioredoxin (trx) 
gene in cyanobacteria (27). Under normal growth conditions, RexT is bound to the 
promoter region of the trxA2 gene. During oxidative stress, H2O2 inhibits the DNA 
binding activity of RexT by oxidizing two of the three cysteine residues to form a 
disulfide bond. RexT is released from the promoter and trxA2 is derepressed. TrxA2 
reduces RexT back to its DNA binding state to repress the trxA2 gene once oxidant has 
been removed from the cell. Thus, similar to OxyR, RexT senses oxidant via redox-
sensitive cysteines and induces expression of Trx to prevent damage in the cell (27).  
PerR is a ferric uptake repressor homolog involved in the H2O2 stress response 
in Bacillus subtilis (28). Its regulon includes genes encoding catalase and 
alkylhydroperoxide reductase, both of which are involved in the detoxification of H2O2 
(29). Although the typical mechanism for H2O2 sensing is through cysteine residues as 
described for OxyR and RexT, PerR senses H2O2 via metal-catalyzed oxidation of 
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histidine residues (29). PerR is a homodimer with two metal ions per subunit. Four 
cysteines coordinate zinc(II) and three histidines and two aspartates coordinate iron(II) 
(30). The incorporated iron(II) interacts with H2O2 to form iron(III), hydroxide ion and 









hydroxyl radical then interacts with one of the histidines involved in coordinating the 
iron ion by incorporating oxygen into histidine to form a 2-oxo-histidine residue in each 
subunit (30). This induces a conformational change in PerR that releases it from DNA 
and derepresses its regulon for the detoxification of peroxides.  PerR also represses the 
uptake of iron when H2O2 is present in the cell because iron can react with H2O2 to form 
a hydroxyl radical (25). It is unknown if 2-oxo-histidine can be reverted back to 
histidine, insinuating that PerR may be a sacrificial regulator during oxidative stress and 
cannot be regenerated following metal-catalyzed oxidation of histidine (30).  
To date only three redox-sensing archaeal regulators are known: SurR, RosR 
and MsvR, the latter of which is the focus of this thesis. The first redox-sensing 
transcription regulator that was discovered in an archaeon was the sulfur response 
regulator SurR, which was found in the hyperthermophilic anaerobe Pyrococcus 
furiosus (31). This organism normally ferments carbohydrates to organic acids, CO2 and 
hydrogen (H2). When elemental sulfur (S
0
) is present, metabolism in the cell switches 
from the production of H2 to the production of hydrogen sulfide (H2S) within minutes 
(32). SurR is a homodimer with each monomer containing N- and C-terminal winged 
HTH DNA binding domains and two cysteine residues in the motif CXXC (33). When 
S
0
 is not present, SurR is in its reduced state and binds to multiple promoters in its 
regulon. It activates hydrogenases and other genes involved in H2 production by 
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recruiting the basal transcriptional machinery to the promoter. SurR also represses 
transcription of numerous sulfur response genes by blocking the transcriptional 
machinery from being able to access the promoter. Upon introduction of S
0
, the two 
cysteines in the CXXC motif in SurR become oxidized and form a disulfide bond. This 
causes a conformational change in the protein that releases it from the DNA, thus 
activating transcription of the sulfur response genes and causing the cell to shift from H2 
to H2S production. As S
0
 becomes depleted in the cell, SurR is converted back to its 
reduced state and H2 production resumes (33). 
The reactive oxygen species regulator RosR is unique to a small clade of 
halophilic archaea and was initially found in the extreme halophile Halobacterium 
salinarum (34). RosR has a central winged HTH domain flanked by effector domains at 
each terminus. It is a bifunctional regulator that plays an important role in a large 
regulatory network that enables H. salinarum to survive extreme oxidative stress by 
quickly responding to the presence of ROS and returning the cell to homeostasis. RosR 
directly regulates over 100 genes with putative functions in transcription, stress 
response, translation and other cellular functions. A structure for RosR has yet to be 
elucidated and no cysteines are present in the protein, so it is currently unknown how or 
if RosR senses oxidant directly and how the regulatory cascade in response to ROS is 
initiated (35). 
The third redox-sensing archaeal transcription factor, MsvR, was initially 
identified in the M. thermautotrophicus genome where it is located upstream and 
divergently transcribed from the fpaA-rlp-rub operon (6). MsvR is a methanogen-
specific homodimer with an ArsR family winged HTH DNA binding domain and a C-
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terminal vinyl-4-reductase domain (36). An msvR homolog in Methanosarcina 
acetivorans (Ma msvR) is flanked by two genes encoding uncharacterized proteins and 
is currently only known to bind its own promoter (Figure 1B). M. thermautotrophicus 
MsvR (MthMsvR) contains five cysteines in the V4R domain, two of which are part of 
a CX2CX3H motif characteristic of some metal-binding proteins involved in redox-
dependent transcription regulation (5). M. acetivorans MsvR (MaMsvR) contains ten 
cysteines, three of which are conserved in MthMsvR (Figure 2). It is postulated that 
some cysteine residues in each MsvR are involved in redox sensing and conformational 
change similar to the redox sensing mechanisms of OxyR. MsvR binds to its promoter 
in reduced conditions and after exposure to oxidant, it is believed that key cysteine 
residues are oxidized and form disulfide bond(s). This may induce a conformational 
change that releases MsvR from its promoter. In M. thermautotrophicus, release of 
MthMsvR from its promoter allows for expression of the fpaA-rlp-rub operon that is 
hypothesized to be involved in the oxidative stress response (37). This study aims to 
determine cysteine residues in MaMsvR involved in disulfide bond formation through 
site-directed mutagenesis of each cysteine and to identify genes in M. acetivorans that 





















This figure has been adapted from a previous study (5). (A) Alignment of binding boxes 
on Ma PmsvR to those on Mth PmsvR/fpaA. Gray boxes indicate MsvR binding boxes A and 
B on Ma PmsvR and binding boxes 1, 2 and 3 on Mth PmsvR/fpaA. Conserved nucleotides 
are shaded in black. (B) Genomic context for Ma msvR. Ma msvR is flanked by 
MA1457 and MA1459, with black brackets indicating the length of each intergenic 
region (181 bp and 128 bp). Arrows represent the direction of transcription for each 
gene. Dashed lines indicate the placement of the intergenic region just upstream of Ma 
msvR that is zoomed into below. MaMsvR binding boxes A and B are represented by 
solid black lines on each side the nucleotide sequence. The red and gray boxes represent 
the TATA box and BRE, respectively. The bent arrow and +1 indicate the 
transcriptional start site for Ma msvR, represented as a black arrow.  
  
























This figure has been adapted from a previous study (5). Geneious v8 was used to 
generate the alignment. The DNA binding domain and V4R domain are represented by 
red and blue boxes, respectively, over residues in each domain. Conserved cysteines are 
indicated with green boxes and non-conserved cysteines in MaMsvR are indicated by 
gray boxes, with the identifier for each cysteine displayed next to each box. Conserved 
residues are shaded in black.  
 
  




















Chapter 2: Substitutional Analysis of Cysteine Residues in MaMsvR, a Redox-
Sensing Transcription Regulator in Methanosarcina acetivorans 
 
Introduction 
Like MthMsvR, MsvR homologs in Methanobacteriales and 
Methanomicrobiales are also divergently transcribed from an fpaA-rlp-rub operon. The 
intergenic regions between the msvR and fpaA homologs contain three regions of 
conserved inverted repeats designated as boxes 1-3 (37). Box 3, located in between 
boxes 1 and 2, overlaps with the transcription start site of fpaA (Figure 1A). MthMsvR 
represses PfpaA by blocking access to the transcription start site and autoregulates its own 
expression by directly abrogating the TFB/TBP complex from binding to the PmsvR 
TATA box. MthMsvR binds to boxes 1-3 under both oxidizing and reducing conditions 
in vitro as well as to secondary binding sites that have the TTCN9GAA motif. Members 
of Methanosarcinales also have MsvR homologs. However, these msvR homologs are 
not divergently transcribed from fpaA and box 1 is not conserved in the promoter region 
(5). Ma msvR is flanked by two genes encoding uncharacterized proteins and is 
currently only known to bind to its own promoter. MaMsvR binds to boxes A and B 
which correspond to boxes 1 and 2 in M. thermautotrophicus (Figure 1A). All four 
binding boxes contain the partial inverted repeat TTCGTAN4TACGAA. While 
MthMsvR binds PmsvR under both oxidizing and reducing conditions, MaMsvR only 
binds its promoter under reducing conditions, which implies an oxidized environment 
prevents MaMsvR from binding PmsvR (5).  
The V4R domain in MthMsvR contains five cysteines, two of which are part of 
a CX2CX3H motif characteristic of some metal-binding proteins involved in redox-
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sensing transcription regulators. MaMsvR is a homodimer containing ten cysteine 
residues including three cysteines in the V4R domain that are conserved in MthMsvR. 
Two cysteine residues are located in the DNA binding domain (C45 and C63), four are 
in the V4R domain (C206, C225, C232 and C240) and four are in the linker region 
(C89, C114, C145 and C178) (Figure 2). Similar to how OxyR functions, the cysteine 
residues in MaMsvR are believed to sense oxidant (e.g. H2O2) in the cell. It is 
hypothesized that oxidation of these residues induces disulfide bond formation between 
key cysteine residues and triggers a conformational change that releases MaMsvR from 
PmsvR.  
After oxidant has been cleared, most redox-sensing transcription regulators are 
restored by disulfide reduction (36). In most organisms, a thioredoxin and/or 
glutathione system is present to reduce disulfides in the target protein to regenerate free 
thiols and reactivate the protein (37). Methanogens have thioredoxins, which are small 
proteins with a CXXC motif in the active site that catalyze oxidoreductase reactions 
through thiol-disulfide exchange (38). The two cysteines in thioredoxin form a disulfide 
bond and the free thiols in the target protein are regenerated. Thioredoxins must be 
enzymatically converted back to their reduced state by TrxR, which uses NADPH as an 
electron donor (39). M. acetivorans has seven putative Trx homologs (MaTrx1-7), one 
TrxR homolog (MaTrxR) and a complete NADPH-dependent thioredoxin system 
comprised of MaTrx7 and MaTrxR (40). MaTrx7 was demonstrated to specifically 
reduce disulfides in MaMsvR with reducing equivalents from MaTrxR and NADPH.  
In a previous study, the four cysteines in the V4R domain of MaMsvR were 
individually mutated to alanine to test the impact each cysteine had on MaMsvR 
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binding to PmsvR (5). It was hypothesized that the three conserved cysteines (C206, C232 
and C240) played an important role in redox sensing. C206 and C232 were determined 
to be important for MaMsvR redox sensing while C225 (the only non-conserved 
cysteine in the V4R domain of MaMsvR) was not. C240 appeared to be involved in 
redox sensing but the variant complex was not stable and did not provide conclusive 
results (5).  
It is postulated that disulfide formation causes a conformational change in 
MaMsvR that releases it from its promoter and allows RNAP to bind PmsvR and proceed 
with transcription. Chapter 2 of this thesis focuses on which cysteines play a role in the 




. To accomplish this goal, 
alanine or serine was individually substituted for each cysteine. It was found that seven 
cysteine residues in MaMsvR are likely involved redox sensing after H2O2 exposure. If 
these are all involved in disulfide bonds, there is a possibility for seven intermolecular, 
three intramolecular and one intermolecular or some combination of intra/inter-
molecular disulfide bonds to form.  
 
Materials and Methods 
 
DNA Purification and Quantitation 
PCR products, gene fragments and digested DNA were purified using the Clean 
& Concentrator™ kit (Zymo Research). Purification of DNA for use in Electrophoretic 
Mobility Shift Assays (EMSA) was performed using the Wizard® SV Gel and PCR 
Clean-Up System (Promega). All plasmids were purified using the Zyppy™ Plasmid 
Miniprep Kit (Zymo Research). All DNA was quantified using the Qubit® dsDNA 
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Broad Range Assay Kit and the original version of the Qubit® fluorometer (Thermo 
Fisher Scientific). All purifications and quantifications were performed as per each 
manufacturer’s instructions, with the exception of eluting DNA into 1 M Tris at pH 8.0 
instead of H2O.   
 
Generation of MaMsvR Variants 
Template: 
E. coli DH5α strain number LK1341 harbors plasmid pLK314, which is 
comprised of full-length Ma msvR in the backbone vector pQE80LNS that encodes for 
an N-terminal Strep- tag II (Qiagen). A scrape of LK1341 was taken from the glycerol 
stock stored at -80°C and incubated for 16-18 hours at 37°C and shaken at 250 rpm in 
25 mL of LB media (per liter of distilled deionized H2O (ddH2O): 10 g tryptone, 5 g 
yeast extract and 5 g NaCl) containing 100 µg mL
-1
 ampicillin. The plasmid pLK314 
was purified and stored at -20°C until it was used as a template for generating cysteine 
to alanine/serine mutations in the Ma msvR construct. Wild-type (WT) strains are listed 
in Table 1 and all plasmids are listed in Table 2. 
 
Primers: 
Two pairs of primers were used for overlapping PCR: a pair of complementary 
primers that contained the point mutation and annealed to the desired mutation site on 
the template strands, and the primer pair LK414 and LK415 that flanked Ma msvR on 






All overlapping PCR reactions used Phusion® High-Fidelity DNA polymerase 
(New England Biolabs®) to extend template strands. PCR reactions were run under the 
following thermal cycling conditions: 30 seconds at 98°C for initial denaturation 
followed by 30 cycles of 10 seconds at 98°C for denaturation, 30 seconds at 65 °C for 
primer annealing and 45 seconds at 72 °C for extension, and final extension at 72 °C for 
5 minutes. 
Two rounds of PCR were utilized to generate Ma msvR variants. The first round 
of PCR consisted of two separate PCR reactions. One reaction contained pLK314 along 
with LK414, the forward primer that annealed to the 5’ end of the vector, and a second 
primer that contained the desired mutation and bound within Ma msvR at the site of 
mutagenesis. The second PCR reaction contained pLK314 along with LK415, which is 
the reverse primer that bound to the 3’ end of the vector, and a primer containing the 
desired mutation that annealed within Ma msvR. PCR products were cleaned up and 
used as template for the second round of PCR. 
Equal volumes of each reaction from the first round were combined for the 
second round of PCR. The complementarity of the internal primers allowed the 
template strands to anneal to each other and primers LK414 and LK415 allowed for 
extension of the template to produce amplicons of full-length Ma msvR that contained 
the desired mutation. The size of the product was confirmed by running an aliquot of 
each sample on a 1% agarose gel at 120 V and 350 mA for 30 minutes. The gel was 
imaged with short wave UV light on a GelDoc™ system (Bio-Rad) and image color 
was inverted for ease of viewing. 
15 
Cloning and Transformation: 
Amplicons and pQE80LNS were digested using FastDigest® BamHI and PstI 
(Thermo Fisher Scientific) in amounts outlined by the manufacturer. The reaction 
mixtures were incubated at 37°C for 1-2 hours to allow for complete digestion at the 
restriction sites and the digested DNA was then cleaned up as previously described. 
The digested Ma msvR variant was ligated to digested pQE80LNS using T4 DNA ligase 
(New England Biolabs®). The reaction mixture was incubated at room temperature 
(RT) for 30 minutes and the remainder left after transformation was kept at RT 
overnight to allow for further ligation. 
E. coli DH5α competent cells were prepared according to the Inoue method 
(41). Five µL of the ligation reaction was incubated with 100 µL of competent E. coli 
DH5α cells for 30 minutes on ice. The cells were heat shocked at 42°C for 90 seconds 
and then immediately transferred to ice for a 90 second incubation. Then 900 µL of LB 
was added to the cells and gently mixed by pipetting up and down. The tube of cells 
was shaken at 100 rpm inside an Erlenmeyer flask for 1 hour at 37°C. Cells were 
pelleted by centrifuging for 1 minute at 14,000 rpm. Then 900 µL of supernatant was 
removed and cells were resuspended in the remaining 100 µL of supernatant. 
Resuspended cells were plated on LB agar (per liter of ddH2O: 10 g tryptone, 5 g yeast 
extract, 5 g NaCl, 15 g agar) that contained 100 µg mL
-1
 ampicillin, and incubated for 






Colony PCR was utilized to screen for colonies of cells that contained the 
previously transformed plasmid. Individual colonies were randomly picked from the LB 
agar plate and resuspended in PCR master mix. Primers LK414 and LK415 and 
GoTaq® DNA polymerase (Promega) were added to the reaction mix. PCR products 
were run on a 1% agarose gel at 120 V and 350 mA for 30 minutes to determine which 
colonies contained the DNA insert. The gel was imaged with short wave UV light on a 
GelDoc™ system (Bio-Rad) and image color was inverted for ease of viewing. 
 
Plasmid Sequencing: 
Colonies that were shown to have the plasmid of interest were picked from the 
plate and suspended in 5 mL of LB media that contained 100 µg mL
-1
 of ampicillin. The 
cultures were incubated for 16-18 hours at 37°C and shaken at 250 rpm. Plasmids were 
purified and sent with primers LK414 and LK415 to the Oklahoma Medical Research 
Foundation DNA Sequencing facility for sequence confirmation. Sequences were 
compared to WT Ma msvR using Geneious v8 and one plasmid containing the Ma msvR 
insert with only the desired mutation was chosen to serve as the stock for that particular 
variant.  
 
Overexpression of MaMsvR Variants 
Transformation: 
E. coli Rosetta™ (Novagen) competent cells were prepared according to the 
Inoue method (41). Two µL of pQE80LNS plasmid containing the sequence-confirmed 
Ma msvR variant was incubated with 50 µL of competent E. coli Rosetta™ cells for 30 
17 
minutes on ice. The cells were heat shocked at 42°C for 90 seconds and then 
immediately transferred to ice for a 90 second incubation. Then 950 µL of LB media 
was added to the cells and gently mixed by pipetting up and down. The tube of cells 
was shaken at 100 rpm inside an Erlenmeyer flask for 1 hour at 37°C. Cells were 
pelleted by centrifuging for 1 minute at 14,000 rpm. Then 900 µL of supernatant was 
removed and cells were resuspended in the remaining 100 µL of supernatant. 







of chloramphenicol, and incubated for 16-18 hours at 37°C. 
 
Auto-Induction: 
Colonies were picked from the plate and suspended in 10 mL of LB media that 
contained 100 µg mL
-1
 of ampicillin and 100 µg mL
-1 
of chloramphenicol. The cultures 
were incubated for 16-18 hours at 37°C and shaken at 250 rpm. The following day, each 
10 mL culture was pelleted down 2 mL at a time by centrifuging for 1 minute at 14,000 
rpm. Supernatant was removed and discarded before pipetting 2 more mL into the tube 
for further centrifugation until 10 ml of culture was pelleted. A culture that served as the 
uninduced control was made by pipetting 70 µL of overnight culture into 7 mL of LB 
media that contained 100 µg mL
-1
 of ampicillin and 100 µg mL
-1 
of chloramphenicol. 
Each 10 mL pellet was resuspended in 1 mL of ZY media (per liter: 10 grams 
tryptone, 5 grams yeast extract, 925 mL ddH2O, 1 mL of 1 M MgSO4, 1 mL of 1000x 
trace metals, 20 mL of 50x 5052, 50 mL of 20x NPS, 1 mL of 100 µg mL
-1
 ampicillin 
and 1 mL of 100 µg mL
-1
 chloramphenicol) and then poured into 1 L of ZY media 
(Table 5). The flasks containing the cultures for auto-induction and the culture of 
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uninduced cells were incubated for 5 hours at 37°C and 250 rpm and then for 16 hours 
at 22°C and 250 rpm.  
After incubation, 1 mL of auto-induced culture and 1 mL of uninduced culture 
were pelleted via centrifugation at 14,000 rpm for 1 minute. The supernatant was 
removed and cells were resuspended in 1 mL of ddH2O. Then 20 µL of each culture 
was transferred to a clean tube and 20 µL of Laemmli buffer (Bio-Rad) that contained 
355 mM β-mercaptoethanol (per 1 mL of Laemmli buffer) was added to each culture. 
Cultures were boiled for 5 minutes and run on a 15% SDS-PAGE gel for 40-50 minutes 
at 200 V and 350 mA to confirm the auto-induction was successful. Auto-induced 
cultures were pelleted in 200 mL bottles at 8,900 rpm for 15 mins at 4°C. The 
supernatant was discarded and the pellet was scraped into a 50 mL conical tube, 
weighed, and then stored at -80°C. 
 
Protein Purification 
MaMsvR variants were purified under non-reducing conditions from E. coli 
cells using a Strep-Tactin Superflow Plus (Qiagen) column that bound the N-terminal 
Strep-tag II on the protein. Cell pellets were thawed on ice and resuspended in 5 mL of 
NP buffer (per liter: 6.9 g NaH2PO4 • H2O, 17.54 g NaCl, pH 8.0 with NaOH) per 1 g of 
pellet. Homogenized cells were then sonicated at 20% amplitude for 20 seconds on and 
60 seconds off for a total of 5 minutes on time. Cellular debris was removed by 
centrifugation at 8,900 rpm for 15 minutes at 4°C. The resulting supernatant was used 
for protein purification. The 500 µL column was set up by pipetting 1 mL of Strep-
Tactin Superflow Plus (50% slurry) (Qiagen) into a 20 mL polypropylene column. Each 
column was used up to 5 times before it was discarded. Cell lysate was run over the 
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column twice before the column was washed with 20 mL of NP buffer. Protein was 
eluted 6 times by pipetting 500 µL of NPD buffer (per liter: 6.9 g NaH2PO4 • H2O, 
17.54 g NaCl, 0.54 g desthiobiotin, pH 8.0 with NaOH) over the column.  
After purification, the column was stripped according to manufacturer’s 
guidelines and stored at 4°C with NP buffer over the column. The six elutions, along 
with samples from the pellet, lysate, column flow through and wash were mixed with a 
1:1 ratio of Laemmli buffer (Bio-Rad) that contained 355 mM β-mercaptoethanol (per 1 
mL of Laemmli buffer) and boiled for 5 minutes. Samples were then run on a 15% 
SDS-PAGE gel for 40-50 minutes at 200 V and 350 mA to confirm protein was eluted 
and clean. Elutions that contained the highest concentrations of protein were combined 
in a DiaEasy™ Dialyzer MWCO 6-8 kDa (BioVision) for dialysis in PDB (per liter: 
2.42 g Tris base, 14.91 g KCl, 0.95 g MgCl2, 500 mL glycerol, brought to volume with 
H2O) overnight at 4°C. Dialyzed protein was then quantified via Pierce™ Coomassie 
Plus (Bradford) Assay Kit (Thermo Fisher Scientific). 
 
Size Exclusion Chromatography 
MaMsvR variants C63A, C89A, C148, C175, C206A, 2CtoA and 3CtoA were 
run on size exclusion chromatography (SEC) at the Protein Production Core Facility at 
the University of Oklahoma using ÄKTA pure M1 with accompanying UNICORN 
software (GE Healthcare). Samples were run on a Superdex-200 Increase column in 
SEC buffer (150 mM NaCl, 20 mM tris hcl, pH 8.0) at 4°C. The column was 
standardized with the following markers: carbonic anhydrase from bovine erythrocytes 
(29 kDa), conalbumin from chicken egg white (75 kDa), ferritin from horse spleen (440 
kDa) and blue dextran 2000 (2,000 kDa). The blue dextran marker gives the void 
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volume for the column. All standard are from the low molecular weight and high 
molecular weight gel filtration calibration kits (GE Healthcare). 
 
Electrophoretic Mobility Shift Assay 
Half of each protein stock was pretreated with 100x H2O2, 1 mM diamide (final 
conc.) or 1 mM paraquat (final conc.) and incubated at RT for 30 minutes prior to 
setting up the reactions. Pretreatment with an oxidizing agent was done to ensure 
complete oxidation of MaMsvR variants. Each EMSA master mix contained 6.5 µl 
ddH2O, 2 µl of 10x Txn buffer (per 10 mL: 200 mM Tris pH 8, 100 mM MgCl2, 1.2 M 
KCl), 3 µl PDB, 0.5 µl heparin (125 mg ml
-1
), and 2 µl of a 500 nM stock of a 100-base 
pair (bp) fragment of PmsvR. Then 14 µl of master mix was pipetted into each reaction 
tube. For oxidized reactions, 4 µl of 10 µM oxidizing agent was added (H2O2, diamide 
or paraquat). For reduced reactions, 1 µl of 100 mM DTT and 3 µl of ddH2O were 
added to each tube. Then 2 µl of MaMsvR (in PDB) was added to each reaction so that 
MaMsvR pretreated with a particular oxidant was used for EMSA reactions containing 
that same oxidant. MaMsvR concentrations are listed in figure legends. EMSA 
reactions were incubated at RT for 15 minutes while a 6-8% tris-borate (TB) gel pre-ran 
for 15 minutes at 200 V and 100 mA. After incubation, EMSA reactions were run on 6-
8% TB gels for 35 minutes at 200 V and 100 mA. Gels were stained with SYBR 
Gold™ (Invitrogen) for 30 minutes and imaged with short wave UV light on a 





Generation of MaMsvR Homology Model 
The amino acid sequence of MaMsvR was uploaded to Protein 
Homology/analogY Recognition Engine v2.0 (Phyre2) to predict the tertiary structure 
of monomeric MaMsvR (42). Nine templates were utilized to model MaMsvR based on 
heuristics that maximized confidence, percentage identity and alignment coverage. The 
predicted structure included 99% of its residues modelled at 99% confidence (42). 
PyMOL was utilized to visualize the homology model and measure distances between 
cysteine residues (43). Further molecular graphics and surface topology analyses were 
performed with the UCSF Chimera package (44, 45).  
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Invitrogen None DH5α None None 
Novagen None Rosetta None Cam 
LK1341 pLK314 DH5α None Amp 
LK1359 pLK350 DH5α C240S Amp 
LK1377 pLK350 Rosetta C240S Amp, Cam 
LK1391 pLK360 DH5α C232A Amp 
LK1392 pLK361 DH5α C206A Amp 
LK1396 pLK360 Rosetta C232A Amp, Cam 
LK1397 pLK361 Rosetta C206A Amp, Cam 
LK1457 pLK393 Rosetta C45A Amp, Cam 
LK1470 pLK401 DH5α C63A Amp 
LK1487 pLK401 Rosetta C63A Amp, Cam 
LK1488 pLK414 DH5α C89A Amp 
LK1489 pLK415 DH5α C114A Amp 
LK1490 pLK415 Rosetta C114A Amp, Cam 
LK1491 pLK416 DH5α C148A Amp 
LK1508 pLK414 Rosetta C89A Amp, Cam 
LK1510 pLK416 Rosetta C148A Amp, Cam 
LK1511 pLK426 DH5α C175A Amp 
LK1512 pLK426 Rosetta C175A Amp, Cam 
LK1515 pLK427 DH5α C45A, C225A Amp 
LK1524 pLK427 Rosetta C45A, C225A Amp, Cam 
LK1538 pLK440 DH5α C45A, C114A, C225A Kan 
LK1540 pLK442 DH5α C45A, C114A, C225A Amp 
LK1547 pLK442 Rosetta C45A, C114A, C225A Amp, Cam 
LK1554 pLK452 DH5α C45A, C114A, C225A, C240S Amp 
LK1555 pLK452 Rosetta C45A, C114A, C225A, C240S Amp, Cam 
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pQE80LNS  N/A 





 expression construct This study 
pLK350 pQE80LNS MaMsvR
C240S
 expression construct This study 
pLK360 pQE80LNS MaMsvR
C232A
 expression construct This study 
pLK361 pQE80LNS MaMsvR
C206A
 expression construct This study 
pLK393 pQE80LNS MaMsvR
C45A
 expression construct This study 
pLK401 pQE80LNS MaMsvR
C63A
 expression construct This study 
pLK414 pQE80LNS MaMsvR
C89A
 expression construct This study 
pLK415 pQE80LNS MaMsvR
C114A
 expression construct This study 
pLK416 pQE80LNS MaMsvR
C148A
 expression construct This study 
pLK426 pQE80LNS MaMsvR
C175A
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Table 3. Primers 
Primer 
Number 
Sequence (5’ to 3’) Function 
LK414 CCCGAAAAGTGCCACCTG Forward primer for PQE80LNS vector 
LK415 GTTCTGAGGTCATTACTGG Reverse primer for PQE80LNS vector 
LK588 TTCAGGGATCCATGGCAAAACCT
GAGACCA 
Ma msvR cloning with BamHI site 
LK589 TTCAGCTGCAGTTATATTGTAATC
TCAAAAAGACAG 
Ma msvR cloning with PstI site 
LK677 TTCAGCTGCAGTTATATTGTAATC
TCAAAAAGACTGCG 
LK589 extended for C240S change in Ma msvR 
LK719 GGAAAACCTCTCGCTGTGCTTAG
AGAAGGC 
Forward primer for C206A variant in Ma msvR 
LK720 GCCTTCTCTAAGCACAGCGAGAG
GTTTTCC 
Reverse primer for C206A variant in Ma msvR  
LK721 GGTCCTGGAAACCGAGGCTTATG
GGACCGG 
Forward primer for C232A variant in Ma msvR 
LK722 CCGGTCCCATAAGCCTCGGTTTC
CAGGACC 
Reverse primer for C232A variant in Ma msvR 
LK723 GGGACCGGGCACACACGCGCTCT
TTTTGAGATTAC 
Forward primer for C240A variant in Ma msvR 
LK724 GTAATCTCAAAAAGAGCGCGTGT
GTGCCCGGTCCC 
Reverse primer for C240A variant in Ma msvR 
LK821 TGACGAAATTGTTAAAGCTACGG
CAAAAGCCAAAT 
Forward primer for C45A variant in Ma msvR 
LK822 ATTTGGCTTTTGCCGTAGCTTTAA
CAATTTCGTCA 
Reverse primer for C45A variant in Ma msvR 
LK823 CAATAATCTAAGAACAGCCGAGC
TTGTTGAA 
Forward primer for C63A variant in Ma msvR 
LK824 TTCAACAAGCTCGGCTGTTCTTA
GATTATTG 
Reverse primer for C63A variant in Ma msvR 
LK841 ACTTCCCAGTACATGGGCGCCTC
TCAGGAGCCTTTT 
Forward primer for C89A variant in Ma msvR 
LK842 AAAAGGCTCCTGAGAGGCGCCC
ATGTACTGGGAAGT 
Reverse primer for C89A variant in Ma msvR 
LK849 GGAAATGACAGGTTCGCCTTTAT
GGAAGCCCTT 
Forward primer for C114A variant in Ma msvR 
LK850 AAGGGCTTCCATAAAGGCGAACC
TGTCATTTCC 
Reverse primer for C114A variant in Ma msvR 
LK851 AGAGATATTGGGAAGGCTCTTTC
GGCTAATTTT 
Forward primer for C148A variant in Ma msvR 
LK852 AAAATTAGCCGAAAGAGCCTTCC
CAATATCTCT 
Reverse primer for C148A variant in Ma msvR 
LK853 GAATTTCACGGGGACGCCCGGGT
CTCGGTCCTC 
Forward primer for C175A variant in Ma msvR 
LK854 GAGGACCGAGACCCGGGCGTCC
CCGTGAAATTC 
Reverse primer for C175A variant in Ma msvR 
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Table 4. MaMsvR variants with multiple substitutions 
MaMsvR Variant Name Substitutions Present 
MaMsvR
2CtoA
 C45A, C225A 
MaMsvR
3CtoA
 C45A, C114A, C225A 
MaMsvR
4CtoN
 C45A, C114A, C225A, C240S 
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Table 5. Recipes for solutions added to ZY media 
 
1000x trace metals (per 100 mL): 
Component Amount added 
FeCl3  1.35 g 
CaCl2  0.294 g 
MnCl2 ∙ 4 H2O  0.198 g 
ZnSO4 ∙ 7 H2O 0.2875 g 
CoCl2 ∙ 6 H2O 0.0476 g 
CuCl2 ∙ 2 H2O 0.0341 g 
NiCl2 ∙ 6 H2O 0.0475 g 
Na2MoO4 ∙ 2 H2O 0.0484 g 
H3BO3 0.0124 g 
12 M HCl 0.5 mL 
Brought to volume with ddH2O 
  
50x 5052 (per 100 mL): 
Component Amount added 
glycerol 25 g 
ddH2O 73 mL 
glucose 2.5 g 
α-lactose 10 g 
  
20x NPS (per 100 mL): 
Component Amount added 
(NH4)2SO4 6.6 g 
KH2PO4 13.6 g 
Na2HPO4 28.61 g 






Rationale for MaMsvR Variant Analysis 
A common redox-sensing mechanism in transcription regulators involves 
cysteine residues that become oxidized by ROS and often form intermolecular or 
intramolecular disulfide bonds (18-20). Formation of disulfide bonds causes a 
conformational change in the protein that affects its ability to bind its promoter. In the 
case of OxyR, one cysteine residue is oxidized by H2O2 and quickly interacts with the 
second cysteine to form a disulfide bond (25). This interaction induces a conformational 
change that allows OxyR to bind promoters in its regulon and activate or repress 
transcription of genes controlled by those promoters. However, in most cases the 
conformational change prevents the transcription regulator from binding its promoter 
and its regulon is derepressed, as is the case with PerR (29). Evidence suggests 
MaMsvR senses oxidant through a similar mechanism so the focus of this study was on 
elucidating the cysteines residues in MaMsvR that are involved in redox sensing (5). 
 MaMsvR is a homodimer containing ten cysteine residues in each monomer, 
providing dimeric MaMsvR with twenty cysteine residues that may be involved in the 
formation of disulfide bonds upon oxidation. The conventional distance cutoff for two 
cysteine residues to form a disulfide bonds is 2.3 Å (46, 47). However, that distance 
pertains mostly to permanent structural disulfide bonds (48). OxyR contains two 
cysteine residues (C199 and C208) that are separated by 17.3 Å in the reduced form of 
OxyR (49). The cysteines only interact after H2O2 oxidizes the thiol of C199 to form 
sulfenic acid (C199-SOH). C199-SOH then quickly interacts with C208 to form a 
disulfide bond that leads to a conformational change in the regulatory domain (50). The 
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formation of reversible disulfide bonds is influenced by the angle of a cysteine thiol, its 
accessibility to solvent and the intermediate formed upon thiol oxidation (48). When 
these variables were taken into account it was determined that cysteines separated by 
6.2 Å or less have a high probability of forming a disulfide bond (48). This cutoff 
distance was used for analysis of cysteines in the MaMsvR homology model.   
Although a crystal structure for MaMsvR has not been solved, the tertiary 
structure prediction program Phyre2 allowed for the amino acid sequence of MaMsvR 
to be compared to other similar structures from the Protein Data Bank. PyMol was 
utilized to visualize the homology model and look for cysteine residues that may be 
within the distance cutoff to form disulfide bonds. The three conserved cysteines in the 
V4R domain (C206, C232 and C240) were located 3.4-3.8 Å away from one another in 
the homology model. This indicates all three cysteines are within the cutoff distance to 
form disulfide bonds with one another, although disulfide partners cannot be determined 
from the model alone (Figure 3). The only nonconserved cysteine in the V4R domain 
(C225) is too far removed to be involved in an intramolecular disulfide bond with any 
of the cysteines in the V4R domain. The model presented here corroborates previous 
findings that C206, C232 and C240 may be involved in redox sensing and C225 is not. 
Interestingly, the structures used to model the V4R domain contain a bound zinc ion at 
the corresponding residues. To strengthen the argument for involvement of C240 in 
redox sensing and/or conformational change and to analyze the remaining cysteines in 
MaMsvR, alanine or serine was substituted for each cysteine (except for C225) to 
determine cysteines with possible involvement in redox sensing. These findings lead to 

























An intensive Phyre2 search was used to generate a full length homology model of 
MaMsvR using domain homologs in the Protein Data Bank. The DNA binding domain 
is colored in red and the V4R domain in blue. Conserved cysteines are colored in green 
and non-conserved cysteines in black. Distances (Å) between cysteines in the V4R 









Distances between cysteines in V4R domain 
 
C206 C225 C232 
C225 19.8 Å 
  
C232 3.4 Å 21.5 Å 
 
C240 3.4 Å 20.5 Å 3.8 Å 
Figure 3. Distances (Å) between cysteine residues in the V4R domain. 
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Generation of Mutant Ma msvR Constructs 
Overlapping PCR was utilized for site-directed mutagenesis of Ma msvR. 
Alanine was individually substituted for all cysteines in MaMsvR (except for C225) to 
remove the thiol group and abolish its ability to potentially form a disulfide bond upon 
oxidation. A second C240 variant was generated in which serine was substituted for 
cysteine (MaMsvR
C240S
). The MaMsvR homology model placed C240 on the surface of 
the protein and the alanine substitution placed a hydrophobic residue on the solvent-
exposed surface (Figure 4). This may have disrupted the structural integrity of MaMsvR 
and prevented it from functioning properly, leading to the inconclusive results 
previously discussed. MaMsvR
C240S
 was created to avoid this issue while still 
eliminating the thiol group. 
 
Expression and Purification of MaMsvR Variants in E. coli 
Mutated Ma msvR amplicons from overlapping PCR were ligated into 
pQE80LNS, an expression vector containing a lac operator that regulates expression of 
the inserted gene. Resultant plasmids were transformed into the maintenance strain 
DH5α for plasmid storage. Plasmids were also transformed into the E. coli host strain 
Rosetta™ (Novagen), which has been engineered to enhance expression of proteins that 
contain codons rarely used in WT E. coli. MaMsvR was overexpressed via auto-
induction, a method using lactose to induce expression of the gene regulated by the lac 
operator in the expression vector. Purified protein elutions were run on SDS-PAGE to 
confirm expression and purification were successful (Figure 5). SEC was used to 










Figure 4. Molecular surface representation of MaMsvR homology model. 
An intensive Phyre2 search was used to generate a full length homology model of 
MaMsvR using domain homologs in Protein Data Bank. Chimera was used to color 
hydrophobic surface areas in red and hydrophilic surfaces in blue. C240 is labeled and 

























Strep-tag II MaMsvR is 29.2 kDa. (A) Representative image of autoinduction trials of 
MaMsvR variants. Lane 1 shows the Thermo Fisher Scientific Prestained Protein 
Molecular Weight Marker. Lane 2 shows uninduced cell lysate. Lane 3 shows induced 
cell lysate. The band indicating MaMsvR overexpression is labeled with an asterisk. (B) 
Representative image of MaMsvR purification. Lane 1 shows the Thermo Fisher 
Scientific Prestained Protein Molecular Weight Marker. Cell pellet (Lane 2), lysate 
loaded onto column (Lane 3), column flow through (Lane 4), pooled sample of column 
washes (Lane 5), all elutions that were pooled for SEC (Lane 6) and individual elutions 
(Lanes 7-13) are shown. (C) Representative gel image of SEC fractions (Lanes 3-12) 
and fractions that were pooled for analysis (Lane 2). Lane 1 shows the Thermo Fisher 
Scientific Prestained Protein Molecular Weight Marker.  
35 kDa 
25 kDa 
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Figure 6. Representative chromatogram of MaMsvR variant after SEC. 
The standard is colored in red and the sample in light blue. Fraction numbers are 
indicated in red on the x-axis and volume in mL is indicated in black on the x-axis. The 






Analysis of Pmsvr Binding by Single MaMsvR Variants Oxidized with H2O2 
 
The protein-DNA interactions of MaMsvR and its promoter (PmsvR) were tested 
through EMSA. The EMSA technique is based on the fact that protein-DNA complexes 
migrate more slowly through non-denaturing polyacrylamide than free DNA. A 
functional DNA-binding protein is incubated with target DNA and run on a 
polyacrylamide gel to determine if the protein can bind the target DNA in the buffer 
conditions provided. If the protein binds the DNA fragment, the movement of the 
complex through the gel is retarded and a band that is higher in the gel than the band 
produced from unbound DNA is produced. The band representing protein-DNA 
complexes is called a shift. 
A lane for free DNA was always run with the DNA-protein binding reactions to 
generate a baseline for unbound DNA to which the shifts could be compared. Purified 
protein was treated with 100x H2O2 and incubated at RT for 30 minutes to ensure 
complete oxidation of the protein. Oxidized MaMsvR variant stocks were utilized for 
EMSA analysis to ensure the protein remained functional after oxidation. The 
concentrations of MaMsvR variants were titrated over PmsvR in reduced and oxidized 
conditions to determine which variants altered MaMsvR binding of PmsvR.  
MaMsvR variants that behaved like WT MaMsvR (MaMsvR
WT
) during EMSA 
indicated the substitution of alanine/serine for cysteine did not affect MaMsvR binding 
to PmsvR. MaMsvR variants that bound PmsvR in both oxidized and reduced conditions 
suggested the substituted cysteine may be a key player in redox sensing and/or 
conformational change because a disulfide bond either did not form or, if a disulfide 
bond did form, it did not impact MaMsvR binding of PmsvR. It was hypothesized that 
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cysteines in the V4R domain were involved in redox sensing because three of the four 
cysteines are conserved in M. thermautotrophicus and V4R domains are sometimes 







 in the V4R domain. MaMsvR
C225A
 was not analyzed 
due to previous findings that it is not involved in redox sensing. Previously published 
results showed that C206 and C232 impacted MaMsvR binding to PmsvR and C240 may 
impact binding (5). However, the MaMsvR
C240A
 variant complex appeared to be 
unstable so the results were inconclusive.  
 









 was previously shown to bind PmsvR in both oxidized and reduced 
conditions, implicating it as a key cysteine in disulfide bond formation that induced a 





 was shown again to bind PmsvR when oxidized with H2O2 and 




 also bound 
PmsvR, at 20-fold excess protein over PmsvR, under oxidized and reduced conditions 
(Figure 8). Clear results for all three conserved cysteines in the V4R domain were 
obtained and because all three variants bound PmsvR when oxidized with H2O2 and 
reduced with DTT, C206, C232 and C240 appear to play a role in redox sensing and/or 
conformational change. The three residues are also within the cutoff distance to form 




















EMSA to test binding of MaMsvR
C206A
 to PmsvR (50 nM) when oxidized with H2O2 (2 
µM) or reduced with DTT (5 mM). Each shift represents WT or variant MaMsvR 
complexed with PmsvR. The control lane (–) contains no protein. Unbound PmsvR is 
labeled as free DNA. Gel wells are indicated.  
Figure 7. EMSA of MaMsvR
C206A
































 to PmsvR (50 nM) when 
oxidized with H2O2 (2 µM) or reduced with DTT (5 mM). Each shift represents WT or 
variant MaMsvR (20-fold excess) complexed with PmsvR. The control lane (–) contains 
no protein. Unbound PmsvR is labeled as free DNA. Gel wells are indicated.  
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 Based on the MaMsvR homology model generated using Phyre2, both C45 and 
C63 are not located within the 6.5 Å distance cutoff to form intramolecular disulfide 
bonds with any other cysteine residue (Figure 9). C175 is the nearest cysteine residue to 
C45 and they are separated by 16.5 Å. The nearest cysteine to C63 with putative 
involvement in redox sensing and/or conformational change is C89, and they are 




 to PmsvR (at 20-fold 
excess protein over PmsvR) under oxidized and reduced conditions was tested through 
EMSA. MaMsvR
C45A
 behaved like MaMsvR
WT
 and only produced a shift when reduced 
with DTT (Figure 10). This demonstrates that C45 is not a likely participant in redox 
sensing or disulfide bond formation. MaMsvR
C63A
 produced shifts under both oxidized 
and reduced conditions, indicating that C63 may be involved in redox sensing and/or 
conformational change. 
Taken together, the EMSA results for MaMsvR
C45A
 and the isolation of C45 
from other cysteines residues based on the MaMsvR homology model suggest C45 is 
not involved in redox sensing or disulfide bond formation. Although C63 is not located 
within the 6.5 Å cutoff to form intramolecular disulfide bonds with any other cysteine 
residues, the EMSA results suggest it may be involved in redox sensing and/or 
conformational change.  C63 is located at the c-terminal end of the DNA binding 
domain and is separated from C63’ by a distance of approximately 36 Å (not shown). 
These cysteines could possibly be involved in an intermolecular disulfide bond. 
However, a significant conformational change would need to occur in order for the 






An intensive Phyre2 search was used to generate a full length homology model of 
MaMsvR using domain homologs in the Protein Data Bank. The DNA binding domain 
is colored in red and the V4R domain in blue. Conserved cysteines are colored in green 
and non-conserved cysteines in black. Distances (Å) from C45 or C63 to the nearest 
cysteine residues and between C45 and C63 are labeled. 
 
  
Figure 9. Location of C45 and C63 in the DNA binding domain of MaMsvR with 


















 to PmsvR (50 nM) when 
oxidized with H2O2 (2 µM) or reduced with DTT (5 mM). Each shift represents WT or 
variant MaMsvR (20-fold excess over PmsvR) complexed with PmsvR. The control lane (–) 
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 with PmsvR. 
41 









 Based on the MaMsvR homology model, C114 and C148 are located on the 
surface of MaMsvR and C89 and C175 are located near the three cysteines in the V4R 
domain that have been implicated in redox sensing (Figure 11). The nearest cysteine to 
C114 is C175 and they are separated by a distance of 17.3 Å. C89 is the nearest cysteine 
to both C175 and C148; C89 is located 8.3 Å away from C175 and 13.7 Å away from 
C148. EMSA results indicated that MaMsvR
C89A
 bound PmsvR at 10, 20 and 40-fold 
excess over PmsvR under oxidized conditions, although the shifts are faint (Figure 12). 
MaMsvR
C89A
 was the only variant that consistently produced faint shifts from binding 
PmsvR under oxidized conditions and this may the result of weak interactions between 
MaMsvR
C89A
 and PmsvR. Regardless of the faint shifting pattern, C89 may be involved in 
redox sensing and/or conformational change.  
 At 20-fold and 40-fold excess MaMsvR
C114A










 bound PmsvR under oxidizing and reducing conditions 
at 20-fold excess protein over PmsvR (Figure 14). However, the shifted bands for both 
variants are smeared and MaMsvR
C175A
 produced a supershifted band in both oxidized 
and reduced conditions. The supershifted band from MaMsvR
C175A
 may be due to 
binding stoichiometry that differs from all other variants.  The shifted band for 
MaMsvR
WT
 is also smeared, which may indicate smearing produced by the variant 




is the only variant in the linker region that did not bind PmsvR 







 bound PmsvR under both 
oxidized and reduced conditions, implicating C89, C148 and C175 in disulfide bond 
formation. However, disulfide bond partners cannot be determined based on the results 






















An intensive Phyre2 search was used to generate a full length homology model of 
MaMsvR using domain homologs in the Protein Data Bank. The DNA binding domain 
is colored in red, the V4R domain in blue and the linker region in gray. Conserved 
cysteines are colored in green and non-conserved cysteines in black. Distances (Å) 
between cysteines in the linker region to neighboring cysteine residues are labeled and 
shown in the table.  
Distances between cysteines in the linker region and neighboring cysteines 
  C206 C232 C240 C89 C114 C148 
C89 10.2 Å 14.2 Å 12.1 Å       
C114 21.2 Å 22.8 Å 22.5 Å 23.7 Å     
C148 20.8 Å 24.2 Å 22.4 Å 13.7 Å 26.4 Å   
C175 7.7 Å 12.6 Å 9.0 Å 8.3 Å 17.3 Å 18.7 Å 























EMSA to test binding of MaMsvR
C89A
 to PmsvR (50 nM) when oxidized with H2O2 (2 





complexed with PmsvR. The control lane (–) contains no protein. Unbound PmsvR is 
labeled as free DNA. Gel wells are indicated.   






Figure 12. EMSA of MaMsvR
C89A
 titrated over PmsvR. 























EMSA to test binding of MaMsvR
C114A
 to PmsvR (50 nM) when oxidized with H2O2 (2 





complexed with PmsvR. The control lane (–) contains no protein. Unbound PmsvR is 
labeled as free DNA. Gel wells are indicated.   
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Figure 13. EMSA of MaMsvR
C114A

































 to PmsvR (50 nM) when 
oxidized with H2O2 (2 µM) or reduced with DTT (5 mM). Each shift represents WT or 
variant MaMsvR (at 20-fold excess over PmsvR) complexed with PmsvR. The control lane 
(–) contains no protein. Unbound PmsvR is labeled as free DNA. Gel wells are indicated.   
  –            WT
ox
        WT
red
     C148A
ox
   C148A
red
    C175A
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 produced shifts under oxidized and 
reduced conditions. The findings indicate seven cysteines, C63, C89, C148, C175, 
C206, C232 and C240, are possible players in redox sensing and/or conformational 
change. Disulfide bond partners cannot be elucidated from the results presented and 
further research is necessary to determine which cysteines interact with one another. 







did not produce a shifted band with PmsvR in oxidized conditions and are likely not 
involved in redox sensing or conformational change. To confirm these findings a double 
and triple variant was generated for analysis through EMSA. 
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Analysis of Promoter Binding by MaMsvR Variants with Multiple Substitutions 
 MaMsvR variants with multiple substitutions were generated to confirm 
findings that C45, C114 and C225 are not involved in redox sensing and to allow for 
removal of cysteines not relevant to function to facilitate downstream experiments. 
MaMsvR
2CtoA
 included the first two cysteines (C45 and C114) not involved in disulfide 
bond formation and MaMsvR
3CtoA
 contained C45, C114 and C225 (Table 4). A third 
variant consisted of MaMsvR
3CtoA
 plus a C240S variant and is referred to as 
MaMsvR
4CtoN
 here, where N denotes an A/S mutation. MaMsvR
4CtoN 
was generated to 
test if removing one cysteine involved in disulfide bond formation would cause the 
variant to bind PmsvR under both oxidized and reduced conditions. 
 EMSA results indicated the double and triple mutants both behaved like 
MaMsvR
WT
 at 20-fold excess protein over PmsvR (Figure 15). The findings confirm that 
C45, C114 and C225 are likely not involved in disulfide bond formation and those 
residues can be removed to facilitate downstream experiments. Variant MaMsvR
4CtoN
 
bound under both conditions (Figure 16). These results imply that a substitution for any 
of the cysteines involved in disulfide bond formation will alter MaMsvR binding to 
PmsvR. The wells of the gel for MaMsvR
4CtoN
 are darkened from protein that has 
aggregated in the wells. This implies the variant is not stable which may be due to the 



















 to PmsvR (50 nM) when 
oxidized with H2O2 (2 µM) or reduced with DTT (5 mM). All protein samples were at 
20-fold excess over PmsvR. Each shift represents MaMsvR
WT
 or variant MaMsvR 
complexed with PmsvR. The control lane (–) contains no protein. Unbound PmsvR is 
labeled as free DNA. Gel wells are indicated.  
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EMSA to test binding of MaMsvR
4CtoN
 titrated over PmsvR (50 nM) when oxidized with 





 complexed with PmsvR. The control lane (–) contains no protein. Unbound 
PmsvR is labeled as free DNA. Gel wells are indicated. 
  






Figure 16. EMSA of MaMsvR
4CtoN
 with PmsvR. 
  20-fold excess      40-fold excess       20-fold excess        10-fold excess    
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Analysis of Pmsvr Binding by MaMsvR Variants Oxidized with Paraquat and Diamide 
Oxidation of cysteine thiols depends on the specificity of oxidizing agents, 
solvent accessibility, thiol pKa, and a multitude of other factors (48). To get a better 
idea of which cysteines in MaMsvR are susceptible to oxidation, single MaMsvR 
variants were oxidized with diamide and paraquat and compared to EMSA results from 
H2O2-induced cysteine oxidation. Diamide is a thiol-specific oxidizing agent that 
promotes disulfide bond formation (53). Paraquat induces oxidative stress by producing 













 were purified 
and run through SEC prior to EMSA analysis. All EMSAs of MaMsvR variants 
oxidized with diamide or paraquat were only performed once so results from these data 
are preliminary.  
MaMsvR
WT
 (20-fold excess over PmsvR) did not bind PmsvR when oxidized with 
diamide, H2O2 or paraquat (Figures 17-20). This indicates all three oxidizing agents 
successfully oxidized MaMsvR
WT
 under the conditions tested. At 20-fold excess 
MaMsvR
C63A
 over PmsvR, variant MaMsvR
C63A
 bound PmsvR when oxidized with H2O2 
and paraquat, but did not bind PmsvR when oxidized with diamide (Figure 17). Variant 
MaMsvR
C89A
 partially bound PmsvR when oxidized with H2O2, fully bound with paraquat 
and did not bind when oxidized with diamide (Figure 18). Variant MaMsvR
C148A
 bound 
PmsvR when oxidized with H2O2 but did not bind when oxidized with diamide or 
paraquat (Figure 19).  







 all bound PmsvR either fully or partially 
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when oxidized with H2O2 but none of them bound PmsvR when oxidized with diamide. 





 still bound PmsvR after treatment with paraquat (2 µM). Paraquat was 
not used as an oxidizing agent for analyses of other MaMsvR variants. The results 
suggest each cysteine in MaMsvR is sensitive to different oxidants and the activation of 
MaMsvR may depend on which agent is causing oxidative stress. However, it is 








 were oxidized with 





 did not bind PmsvR when oxidized with diamide. 
MaMsvR
C206A
 was the only variant that bound PmsvR when oxidized with diamide. Two 
shifts were produced for MaMsvR
C206A
 binding PmsvR under both oxidized and reduced 
conditions and all shifts with MaMsvR
C206A
 represent partial binding to PmsvR. Another 
lab member purified the MaMsvR
C206A
 variant used for this analysis and the variant 
produced the same two shifts when oxidized with H2O2 (not shown), indicating that 
something was wrong with this preparation. One explanation is partial degradation of 
the protein resulted in complexes of varying molecular weight or aggregated protein. 
The results support the hypothesis that C206 is a key player in redox sensing and/or 
conformational change because all other variants that previously bound PmsvR when 
oxidized with H2O2 were more sensitive than MaMsvR
C206A














EMSA to test binding of MaMsvR
C63A
 (20-fold excess) to PmsvR (50 nM) when oxidized 
with H2O2, diamide or paraquat (all at 2 µM concentration) or reduced with DTT (5 




 complexed with PmsvR. The 
control lane (–) contains no protein. Unbound PmsvR is labeled as free DNA  Gel wells 
are indicated.   
Figure 17. EMSA of MaMsvR
C63A


























EMSA to test binding of MaMsvR
C89A
 (20-fold excess) to PmsvR (50 nM) when oxidized 
with H2O2, diamide or paraquat (all at 2 µM concentration) or reduced with DTT (5 
mM). Each shift represents WT or variant MaMsvR complexed with PmsvR. The control 






Figure 18. EMSA of MaMsvR
C89A






















EMSA to test binding of MaMsvR
C148A
 (20-fold excess) to PmsvR (50 nM) when 
oxidized with H2O2, diamide or paraquat (all at 2 µM concentration) or reduced with 
DTT (5 mM). Each shift represents WT or variant MaMsvR complexed with PmsvR. The 












Figure 19. EMSA of MaMsvR
C148A




























 (all 20-fold 
excess over PmsvR) to PmsvR (50 nM) when oxidized with diamide (2 µM) or reduced with 
DTT (5 mM). Each shift represents MaMsvR
WT 
or variant MaMsvR complexed with 
PmsvR. The control lane (–) contains no protein. Unbound PmsvR is labeled as free DNA. 

























 produced shifts when 
oxidized with H2O2, indicating that the substitutions in these variants prevented the 
conformational change to release MaMsvR from PmsvR. This implicates seven cysteines, 
C63, C89, C148, C175, C206, C232 and C240, as key residues for redox sensing and/or 







did not produce shifted bands when oxidized with H2O2, indicating C45, 
C114 and C225 are not involved in redox sensing or conformational change. 







 further suggests that C45, 
C114 and C225 are not involved in MaMsvR binding PmsvR. Binding to PmsvR under 









 and further implicates C240 as a key 
residue in MaMsvR binding PmsvR. The results from oxidizing MaMsvR variants with 
H2O2, diamide and paraquat suggest that diamide is the strongest of the three oxidizing 
agents for the oxidation of MaMsvR. The only variant that still bound PmsvR when 
oxidized with diamide was MaMsvR
C206A
. This further implicates C206 as a key residue 
in redox sensing and/or conformational change in MaMsvR. 
Of the seven cysteine residues putatively involved in MaMsvR redox sensing 
and/or conformational change, only three residues, C206, C232 and C240, are within 
the distance cutoff to form disulfide bonds. These three cysteines are located in the V4R 
domain of MaMsvR and are conserved in MthMsvR. The V4R domain has been 
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previously implicated in redox sensing and it can be postulated that C206, C232 and/or 
C240 may be involved in redox sensing. The formation of at least one intermolecular 
bond is probable because seven cysteines are implicated in disulfide bond formation. 
Further studies are needed to determine the number of intra- and intermolecular 
disulfide bonds, identify disulfide partners and elucidate the redox-sensing mechanism 






Chapter 3: Preliminary Analysis of the MaMsvR Regulon by RNA-seq  
 
Introduction 
 Methanosarcinae are a diverse group of methanogens that are unparalleled in 
terms of metabolism, physiology and environmental versatility. The M. acetivorans 
genome was sequenced in 2002 and the species’ versatility was demonstrated in its 5.7 
million bp genome, which is the largest genome known for an archaeon (55). Genes 
encoding function in two methanogenesis pathways were found, allowing M. 
acetivorans to grow on a variety of substrates. The two methanogenesis pathways are 
methylotrophic and acetoclastic, which produce methane from methylated compounds 
and acetate, respectively.  
In the methylotrophic methanogenesis pathway, the methyl group from 
methylated compounds (CH3–X) is transferred to a corrinoid protein by a 
methyltransferase (MT1) that is specific for a particular substrate (56). A second 
substrate-specific methyltransferase (MT2) then demethylates the corrinoid protein to 
transfer the methyl group to coenzyme M (CoM) to produce the intermediate methyl-
CoM (CH3–CoM) that is central to the pathway. In the acetoclastic methanogenesis 
pathway, acetate is activated to acetyl-coenzyme A (acetyl-CoA) via two reactions 
catalyzed by acetate kinase (Ack) and phosphotransacetylase (Pta) (57). The acetyl-
CoA decarbonylase/synthase (ACDS) complex then transfers the methyl group from 
acetyl-CoA to tetrahydrosarcinapterin (H4SPt) to generate the intermediate methyl- 
H4SPt and releases CoA and CO2. M. acetivorans has two copies of the six-gene operon 
encoding for the ACDS complex and it has been postulated that this unusual duplication 
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may aid in differential expression of genes encoding acetoclastic methanogenesis 
functions (55). 
The genome also indicated that M. acetivorans has a wide range of responses to 
external stimuli via a two-component signal transduction system (55). Classical two-
component regulatory systems consist of a histidine kinase and a response regulator that 
function in signal transduction (58, 59). Signal transduction cascades may also include 
the second messenger 3’, 5’-cyclic adenosine monophosphate (cAMP), which 
modulates activity of cAMP-dependent protein kinases and is one of the initiating 
components in these signal transduction cascades (60). The level of intracellular cAMP 
is controlled by cAMP phosphodiesterases (Cpd), which are controlled by extracellular 
signals. Histidine kinases sense specific environmental stimuli and autophosphorylate a 
key histidine residue in the kinase domain (61). The phosphate is then transferred to an 
aspartate residue on the receiver domain of the cognate response regulator. The 
activated response regulator then regulates transcription of genes necessary to respond 
to the environmental stimulus that was initially sensed by histidine kinase. The two-
component signal transduction system in M. acetivorans contains 50 genes encoding 
histidine kinases and 18 response regulators (55). 
 Although many of pathways in M. acetivorans have been elucidated, little is 
known about the transcription regulators that modulate them. RNA-seq has been a vital 
tool in the elucidation of regulons of some transcription regulators in M. acetivorans to 
provide insights into the regulation of certain pathways. RNA-seq is a technique that 
uses deep-sequencing technologies for transcriptome profiling (62). RNA is extracted 
from cells and converted to a library of complementary DNA (cDNA) fragments. The 
61 
fragments are sequenced to obtain short sequences from both ends that are between 30-
400 bp in length (62). Reads are then mapped to a reference genome and mRNA 
abundance is quantified to determine levels of gene expression. RNA-seq of a WT 
strain and a strain containing a gene deletion has been used to determine the role the 
gene product plays within the cell. 
MreA (Methanosarcina regulator of energy-converting metabolism) was 
characterized through RNA-seq as a global regulator of energy-converting metabolism 
in M. acetivorans (63). MreA was shown to be involved in the activation of genes 
encoding acetoclastic methanogenesis functions and repression of genes encoding 
methylotrophic methanogenesis functions when cells were grown on acetate. MreA was 
also shown to either directly or indirectly regulate five regulators in the methanol-
specific regulator (Msr) family. Msr regulators modulate expression of genes encoding 
methyltransferases in the methylotrophic methanogenesis pathway (64). The findings 
implicate MreA as a regulator that facilitates the switch between growth substrates in 
M. acetivorans (63). 
 MaMsvR was postulated to be involved in the oxidative stress response in M. 
acetivorans due to its redox sensitivity in vivo and in vitro and the involvement of 
MsvR homologs in oxidative stress in hydrogenotrophic methanogens (37). RNA-seq 
was utilized for preliminary analysis of the MaMsvR regulon to gain insights into 





Materials and Methods 
 
Culturing WT and Ma ΔmsvR Strains 
The RNA-seq analysis compared transcript levels from a M. acetivorans strain 
containing an msvR deletion (Ma ΔmsvR) to a WT M. acetivorans strain (Table 6). The 
WT strain was donated from the Metcalf lab at the University of Illinois and the Ma 
ΔmsvR strain from the Lessner lab at the University of Arkansas. Anaerobic culture 
tubes were filled with 10 mL of high salt (HS) media and had a headspace containing 
80% nitrogen and 20% CO2 (Tables 7 and 8). Then 0.1 mL of 2% Na2S stock solution 
and 0.125 mL of 100% methanol were added to each tube prior to inoculating the media 
with cells. Prior to inoculation, 0.1 mL of a puromycin stock solution (250 µg mL
-1
) 
was added to tubes intended for inoculation with the Ma ΔmsvR strain. A syringe was 
used to transfer 0.1 mL of each strain to a culture tube. Strains were grown in triplicate. 
Cultures were incubated at 37 °C and optical density (OD) was measured and recorded 




When cell cultures reached an OD of approximately 0.5, cells were pelleted by 
centrifugation at 6,000 rpm for 2 minutes. Supernatant was removed and cells were 
resuspended in 1 mL of TRI Reagent® Solution (Ambion®) to lyse cells. Cells were 
stored at -80 °C overnight to aid in cell lysis. Once all samples were ready for 
extraction, 1 mL of 100% ethanol was added to each sample. All six of the samples 
were then split into three samples to serve as technical replicates for the RNA extraction 
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process. RNA was extracted using the Quick-RNA™ MiniPrep kit (Zymo Research) 
according to manufacturer’s protocol. After RNA elution, the three technical replicates 
were pooled together so each biological replicate contained 180 µl of eluted RNA.  
 
RNA Quantification and Preliminary Verification of RNA Quality 
RNA was quantified using the NanoDrop 2000c spectrophotometer (Thermo 
Fisher Scientific). The quality of total RNA was initially checked by running samples 
on a 1% agarose gel at 120 V and 350 mA for 30 minutes. The gel was imaged with 
short wave UV light on a GelDoc™ system (Bio-Rad) and image color was inverted for 
ease of viewing.  
 
RNA Quality Verification on Bioanalyzer 
To ensure the extracted RNA was not degraded, RNA samples were analyzed 
using the RNA 6000 Nano Kit (Agilent) according to manufacturer’s instructions. 
Samples were run on the 2100 Bioanalyzer System (Agilent). 
 
cDNA Library Preparation and RNA-seq 
All six RNA samples were sent to Tufts University Core Facility Genomics 
Core for preparation of cDNA libraries and RNA-seq. The Ribo-Zero rRNA Removal 
Kit (Illumina) was used to deplete rRNA from the samples. Then TruSeq Stranded 
mRNA Library Prep kit (Illumina) was used to prepare a strand-specific and directional 
library from mRNA. Samples were sequenced on the HiSeq 2500 system (Illumina) on 





The reads for each sample were mapped to the M. acetivorans genome using the 
Bowtie 2 plugin in Geneious v8 (65). Genome assemblies that the reads were mapped to 
were then imported into SeqMonk v0.34.1 (Babraham Bioinformatics) for RNA-seq 
analysis. Data was quantitated using the RNA-seq quantitation pipeline. The R-based 
filter DESeq2 pipeline was used to determine differentially expressed genes based on 
raw counts for each gene (66). The false discovery rate (FDR) was calculated for each 
transcript using the DESeq2 pipeline. Differentially expressed genes with a fold-change 
(FC) less than 2.0 were excluded from the results unless they were deemed relevant to 
this study. Genes were separated into two groups depending on whether they were 
upregulated or downregulated in the Ma ΔmsvR strain compared to the WT strain.  
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Table 6. M. acetivorans strains used for RNA-seq 
Strain Genotype Reference 
WWM73 WT 67 
DJL36 ΔmsvR This study 
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Table 7. Recipe for anaerobic HS media 
  
Anaerobic HS Media (per 1 L): 
Component Amount added 
NaCl 23.4 g 
NaHCO3 3.8 g 
KCl 1.0 g 
MgCl2 ∙ 6 H2O 11.0 g 
CaCl2 ∙ 2 H2O 0.3 g 
Trace elements 10 mL 
5x vitamin solution 2.0 mL 
0.2% resazurin 0.5 mL 
  
After heating at 55-60 °C with N2/CO2 bubbling for 30 minutes, add: 
NH4Cl 1 g 
Cysteine 0.5 g 
1 M KH2PO4 5 mL 
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Table 8. Recipes for solutions added to HS media 
  
Trace elements (per 1 L): 
Component Amount added 
nitrolotriacetic acid 1.5 g 
MgSO4 ∙ 7 H2O 3 g 
MnSO4 ∙ H2O 0.5 g 
NaCl 1 g  
Ingredients were dissolved in ddH2O and the pH of the solution was brought 
up to ~7.0 
Post pH adjustment: 
 FeSO4 ∙ 7 H2O 0.1 g 
CoSO4 or CoCl2 0.1 g 
CaCl2  0.1 g 
ZnCl2  0.08 g 
CuSO4  ∙ 5 H2O 0.1 g 
AlK(SO4)2 0.1 g 
H3BO3 0.1 g 
Na molybdate 0.025 g 
NiCl2 ∙ 6 H2O 0.024 g 
  5x vitamin solution (per 1 L): 
Component Amount added 
biotin 0.01 g 
folic acid 0.01 g 
pyridoxine-HCl 0.05 g 
riboflavin 0.025 g 
thiamine 0.025 g 
nicotinic acid 0.025 g 
pantothenic acid 0.025 g 
vitamin B12 0.025 g 
p-aminobenzoic acid 0.025 g 




Rationale for RNA-seq Analysis 
 Elucidating the MaMsvR regulon is imperative to understanding the biological 
role of MaMsvR in M. acetivorans. The mutational analysis of individual cysteines in 
MaMsvR strengthened the hypothesis that MaMsvR senses oxidant in vitro via redox-
sensing cysteine residues but it is currently not known how the redox state of MaMsvR 
affects gene expression or which genes are regulated by MaMsvR. RNA-seq was 
chosen for preliminary analysis of the MaMsvR regulon because it offers accurate 
quantitation of a wide range of expression levels, there is little to no background noise 
and it has higher specificity and sensitivity than microarrays which allows for detection 
of transcripts in low abundance (62). 
RNA was extracted from WT and ΔmsvR M. acetivorans strains grown on 
methanol for RNA-seq analysis (Table 5). The quality of total RNA was initially 
checked by running aliquots of RNA elutions on a non-denaturing agarose gel (Figure 
21).  The sharp and clear 16S and 23S rRNA bands indicated the RNA was intact, and 
the absence of higher molecular weight bands suggested the absence of DNA 
contamination. Although a DNA ladder was run alongside the RNA samples, the 
placement of RNA bands with respect to the DNA ladder was consistent with the 
expected rRNA sizes specified by Thermo Fisher Scientific. RNA samples were then 
run on the 2100 Bioanalyzer System (Agilent) for more in-depth analysis of RNA 
integrity. The results (not shown) corroborated previous findings that all RNA samples 
were intact.  
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Preliminary RNA-seq analysis was completed using the R-based package 
DESeq2 (Bioconductor) available through SeqMonk v0.34.1 (Babraham 
Bioinformatics). DESeq2 estimates variance-mean dependence in raw count data to test 
for differential expression based on a negative binomial distribution model (68). 
SeqMonk v0.34.1 has limited functionality for in-depth and exploratory analyses but 
was chosen as the tool for initial data preparation and quality control (69). Future RNA-
seq analysis will utilize other bioinformatics tools that will provide a deeper analysis of 
























Lane 1 shows the GeneRuler™ 1 kilobase (kb) DNA ladder (Thermo Fisher Scientific). 
Lanes 2-4 show 16S and 23S rRNA bands for the three Ma ΔmsvR biological replicates. 














       1        2        3        4        5        6        7 
Figure 21. RNA integrity checked by agarose gel electrophoresis. 
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General RNA-seq Analysis of Differentially Expressed Genes 
From the DESeq2 analysis, 432 genes (p<0.05, Wald test) were found to be 
differentially expressed in the Ma ΔmsvR versus WT M. acetivorans strains. Of those 
432 genes, 252 genes showed elevated expression and 180 genes showed depressed 
expression in the Ma ΔmsvR strain compared to WT (Tables 10 and 11 in the appendix). 
A fold-change cutoff based on biological relevance was set at 2.0, which lead to 103 
genes that passed the cutoff. Of those 103 genes, 61 genes were upregulated and 42 
genes were downregulated (Ma ΔmsvR/WT). However, all FC cutoffs are arbitrary and 
some genes that were below the cutoff but relevant to the study based on previous 
findings were analyzed further. The 103 differentially expressed genes with a FC≥2.0 
were grouped based on arCOG functional categories (Table 9) (70). Notably, genes with 
putative involvement in the MaMsvR regulon function in methylotrophic and 






Table 9. arCOG functional categories of differentially expressed genes (Ma 
ΔmsvR/WT) with FC≥2.0. 





C Energy production and conversion 21 4 
E Amino acid transport and metabolism 8 1 
G Carbohydrate transport and metabolism 1 0 
H Coenzyme transport and metabolism 0 2 
I Lipid transport and metabolism 1 0 
P Inorganic ion transport and metabolism 1 5 
K Transcription 1 1 
T Signal transduction mechanisms 2 2 
M Cell wall/membrane/envelope biogenesis 1 1 
R General function prediction only 7 10 
S Function unknown  18 16 
  
73 
Preliminary Analysis of Genes Involved in Methanogenesis 
Ten genes involved in methylotrophic methanogenesis were differentially 
expressed and 15 genes involved in acetoclastic methanogenesis showed elevated 
expression in the Ma ΔmsvR strain compared to WT. For methylotrophic 
methanogenesis genes, only one gene was differentially expressed for each substrate-
specific methyltransferase and corrinoid protein (Figure 22). MT1 homologs specific 
for methanol (MA4392), methylamine (MA2972), dimethylamine (MA2425) and 
trimethylamine (MA0528) metabolism were differentially expressed in the Ma ΔmsvR 
strain compared to WT. This trend was also seen in genes encoding for corrinoid 
proteins, where corrinoid proteins specific for methanol (MA4391), methylamine 
(MA2971) and dimethylamine (MA2424) were differentially expressed (Ma 
ΔmsvR/WT). One gene encoding a corrinoid protein specific for an unknown substrate 
(MA4164) was upregulated 4.1-fold in the Ma ΔmsvR strain as well. A methanol-
specific MT2 homolog was upregulated 1.6-fold in the Ma ΔmsvR strain and two MT2 
homologs specific for unknown substrates (MA2163 and MA4165) were differentially 
expressed. Two genes encoding dimethylsulfide-specific proteins with fused MT2 and 
corrinoid domains, mtsD (MA0859) and mtsF (MA4384), were upregulated 8.9-fold 
and 5.2-fold in the Ma ΔmsvR strain, respectively.  
The indirect or direct regulation of one isoform for each substrate-specific MT1, 
MT2 and corrinoid proteins involved in methylotrophic methanogenesis by MaMsvR 
suggests that MaMsvR may modulate expression of these genes based on which 
isozyme functions best under the growth conditions provided. A previous study found 
that mtsF is upregulated under a variety of redox stress conditions, so it is plausible that 
74 
MaMsvR represses mtsF in a redox-dependent manner (71). It cannot be determined 
from the data provided if MaMsvR regulates methylotrophic methanogenesis genes 
based on substrate availability, redox conditions, and/or other cellular factors. 
Almost all of the genes involved in acetoclastic methanogenesis were 
upregulated in the Ma ΔmsvR strain (Figure 23). All 12 genes comprising the duplicate 
ACDS operon along with a third, lone copy of CO dehydrogenase/acetyl-CoA synthase 
(cdhA) were upregulated by FCs greater than 2.0 in the Ma ΔmsvR strain. The genes 
encoding Ack (MA3606) and Pta (MA3607) also showed elevated expression in the Ma 
ΔmsvR strain compared to WT with FCs of 2.0 and 2.3, respectively. In a previous 
study, M. acetivorans cells grown on acetate were shown to have greater expression of 
genes involved in oxidative stress response compared to cells grown on methanol, 
indicating that an oxidative stress response is induced in M. acetivorans cells grown on 
acetate (72). This finding may explain the elevated expression levels of genes involved 
in acetoclastic methanogenesis in the Ma ΔmsvR strain versus the WT strain. MaMsvR 
may be involved in repressing, either directly or indirectly, genes encoding acetoclastic 
methanogenesis function to prevent the cell from metabolizing acetate and thus protect 
it from undergoing oxidative stress. It can be postulated that adapted growth of the Ma 
ΔmsvR strain to acetate would be significantly increased because the acetoclastic 


















This figure has been adapted from a previous study (55). The methylotrophic 
methanogenesis pathway for the conversion of methylated compounds to the 
intermediate methyl-CoM. The gene number for substrate-specific methyltransferases 
and corrinoid proteins involved in methanol (green), methylamine (magenta), 
dimethylamine (purple) and trimethylamine (orange) metabolism are listed. Three genes 
(cyan) encode for dimethylsulfide-specific proteins with fused MT2 and corrinoid 
domains. The substrates for genes listed in black have not been identified yet. The 
expression FC (Ma ΔmsvR/WT) for differentially expressed genes is listed to the right 


















Figure 22. Differential expression of redundant genes encoding methylotrophic 
methanogenesis functions. 
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This figure has been adapted from a previous study to only include data from this study 
(55). The acetoclastic methanogenesis pathway for the conversion of acetate to the 
intermediate methyl-H4SPt. The gene numbers for Ack and Pta are listed with the 
expression FC (Ma Δmsvr/WT) beneath each gene number. Genes encoding two nearly 
identical copies of the ACDS complex are listed with the expression FC to the right of 
the gene number. A third, lone copy of cdhA (MA4399) is listed to the right of the other 
cdhA homologs.   
Figure 23. Upregulated genes in the Ma Δmsvr strain that encode acetoclastic 
methanogenesis functions. 
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Preliminary Analysis of Differentially Expressed Signal Transduction Genes 
 M. acetivorans contains 50 genes encoding histidine kinases and 18 response 
regulators (55). Two response regulators (RR), MA1366 and MA4671, were 
downregulated (Ma ΔmsvR/WT) 1.8-fold and 1.7-fold, respectively. Although the FCs 
do not pass the cutoff of 2.0, it is probable that Ma msvR expression may be linked to 
direct or indirect activation of these two response regulators. A total of 11 histidine 
kinase genes were differentially regulated but only 3 passed the FC cutoff. The histidine 
kinase encoded by MA1957 was downregulated -3.5-fold and histidine kinase genes 
MA0620 and MA0203 were upregulated 2.9-fold and 2.0-fold, respectively. The 
remaining 8 genes encoding histidine kinases had FCs less than 2.0 and included 6 
upregulated genes (MA0619, MA2553, MA1274, MA0777, MA1463 and MA2890) 
and 2 downregulated genes (MA1645 and MA1645).  
One gene (MA1686) encoding cAMP phosphodiesterase (cpdA) was 
downregulated -3.5-fold (Ma ΔmsvR/WT). This further implicates the potential 
involvement of MaMsvR in regulatory signal transduction cascades that affect gene 
expression. The higher number of upregulated histidine kinases suggest MaMsvR may 
be directly or indirectly involved in repressing these signal transduction kinases when 
grown on methanol. M. acetivorans cells grown in the presence of oxygen or other 
stressors may show increased expression of these signal transduction genes. It can be 
imagined that MaMsvR may be involved in a signal transduction regulatory cascade in 
which MaMsvR regulates expression of histidine kinases and response regulators that 
then regulate expression of genes involved in stress response(s). Two response 
regulators have been included in the gene regulatory network (Figure 24) with other 
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transcription regulators putatively involved in the MaMsvR regulon to depict a possible 
hierarchy of regulators in M. acetivorans. 
 
Preliminary Analysis of Differentially Expressed Transcription Regulators 
Two genes encoding putative transcription regulatory proteins were 
differentially expressed (FC≥2.0) in M. acetivorans. An ArsR family transcription 
regulator (MA0504) was expressed 2.1-fold greater in the Ma ΔmsvR strain versus WT 
and SmtB (MA4344), an ArsR family efflux system transcriptional regulator, had a FC 
of -3.1. The findings indicate that the deletion of Ma msvR modulates gene expression, 
either directly or indirectly, by affecting the expression of other transcription regulators. 
This suggests MaMsvR may be involved in a regulatory hierarchy, although the specific 
functions of ArsR and SmtB in M. acetivorans and their interactions with MaMsvR 
have not been elucidated yet.  
 Five other transcription regulators were found to be differentially expressed but 
did not pass the FC cutoff of 2.0. Three regulators (MA3302, MA2914 and MA1424) 
showed upregulated expression and two regulators (MA1101 and MA2782) were 
downregulated.in the Ma ΔmsvR strain versus WT. A global regulator involved in 
energy-converting metabolism, mreA (MA3302), had 1.5-fold greater expression in the 
Ma ΔmsvR strain versus WT (63). MreA was found to modulate expression of genes 
encoding methanogenesis functions by activating acetoclastic methanogenesis genes 
and repressing methylotrophic methanogenesis genes when cells were grown on acetate, 
although it is unknown if this regulation is direct or indirect (63). The data suggests that 
MaMsvR represses expression of mreA either directly or indirectly. This supports the 
findings here that MaMsvR may be involved in modulating acetoclastic methanogenesis 
79 
when grown on methanol by repressing genes functioning in the pathway as well as 
repressing expression of at least one other transcription regulatory protein that regulates 
methanogenesis.  
 From the mreA RNA-seq analysis it was determined that Ma msvR had an 
expression ratio (∆mreA/WT) of 1.7 when strains were grown on acetate (63). Taking 
this into account, along with the 1.5-fold greater expression (Ma ∆msvR/WT) of mreA 
when cells were grown on methanol, implies a mutual repression of both mreA and Ma 
msvR under different growth conditions. Both regulators modulate expression of many 
of the same genes and appear to be involved in the regulation of energy-converting 
metabolism as well as other regulators. A gene regulatory network has been constructed 
to depict the connection between MaMsvR and MreA and the transcription regulators 
differentially expressed in both data sets as well as genes involved in signal 
transduction and methanogenesis pathways (Figure 24). However, it is important to note 
that cells were grown on acetate for RNA-seq analysis of mreA and on methanol for Ma 
msvR RNA-seq analysis. It cannot be determined if regulation by either regulator is 
direct or indirect, so the mechanisms linking the two regulators cannot be elucidated 
yet. It is possible that the upregulation of genes encoding acetoclastic methanogenesis 
function in the Ma ∆msvR strain was due to mreA being upregulated in that strain as 
well. Further studies are needed to determine genes directly regulated by MaMsvR. 
 The two other predicted transcription regulators with elevated expression in Ma 
ΔmsvR compared to WT, MA2914 and MA1424, both belong to the HTH-3 family of 
transcription regulators and had expression FCs of 1.35 and 1.26, respectively. These 
regulators have not been characterized yet but their upregulated expression in the Ma 
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ΔmsvR strain suggests that the repertoire of gene regulation by MaMsvR may be 
expanded by its modulation of other transcription factors and response regulators. 
 Two regulators (MA1101 and MA2782) were downregulated in the Ma ΔmsvR 
strain compared to WT. An uncharacterized regulator (MA1101) was downregulated     
1.3-fold and a TetR family regulator (MA2782) was downregulated 1.7-fold. The TetR 
family of regulators is involved in transcription control of genes encoding stress 
response functions such as multidrug efflux pumps, osmotic stress response and 
removal and degradation of toxins (73). The deletion of Ma msvR from M. acetivorans 
causing decreased expression of MA2782 suggests that MaMsvR may be involved in a 





















The black oval represents Ma msvR. Transcription regulators putatively involved in 
MaMsvR and/or MreA regulons are depicted as dark red ovals. Genes encoding for two 
response regulators and one histidine kinase are depicted as gray rectangles. The blue 
rectangle represents genes involved in acetoclastic methanogenesis. Two genes 
encoding for methyltransferases involved in methylotrophic methanogenesis are 
depicted as purple diamonds. Dashed lines with blunt ends represent repression and 
solid arrows indicate activation or derepression by a transcription regulator. The double 
line indicates indirect regulation. All other regulatory connections may be either direct 
or indirect. 
 
Figure 24. Predicted MaMsvR gene regulatory network. 
 








The preliminary RNA-seq results suggest MaMsvR directly or indirectly 
regulates genes encoding function in methanogenesis, signal transduction, transcription 
regulation and various other cellular functions. MaMsvR was initially believed to be 
involved in the oxidative stress response in M. acetivorans but the RNA-seq data 
implicates MaMsvR as a redox-sensitive regulator of central metabolism due to its 
direct or indirect involvement in: (i) repression of acetoclastic methanogenesis genes 
when cells were grown on methanol, (ii) activation and repression of genes encoding 
methylotrophic methanogenesis function and (iii) regulation of MreA, a regulator of 
both acetoclastic and methylotrophic methanogenesis pathways. In this way, MaMsvR 
may function similarly to SurR, a redox-sensitive regulator in P. furiosus that senses S
0 
in the environment and regulates the switch from the production of H2 to the production 
of H2S (33). The findings indicate MaMsvR may be involved in the switch between 
growth substrates and/or the redox-dependent regulation of methanogenesis genes.  
Further experiments are needed to better assess the MaMsvR regulon. RNA-seq 
experiments of M. acetivorans cells grown on different substrates and under different 
redox conditions will aid in the elucidation of the MaMsvR regulon and the 
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Appendix: RNA-seq Data Tables 
Table 10. Upregulated transcripts in Ma ΔmsvR 








Methanogenic corrinoid protein 
with fused MT2 domain  (mtbC1) 
C 0 3.15 8.87 
MA4563 hydantoinase (hyuA) E 0 2.61 6.09 
MA1124 hypothetical protein S 7.09E-22 2.59 6.03 
MA4384 
Methanogenic corrinoid protein 
with fused MT2 domain (mtbC1) 
C 3.91E-17 2.39 5.24 
MA0848 hypothetical protein S 3.19E-15 2.20 4.60 
MA3319 hypothetical protein S 1.05E-14 2.15 4.44 
MA3318 hypothetical protein S 3.56E-25 2.11 4.33 
MA4164 
Methanogenic corrinoid protein 
(mtbC1) 
C 7.95E-19 2.05 4.15 
MA4391 
Methanogenic corrinoid protein 
(mtaC2) 
C 0.0028 1.80 3.48 
MA1015 ACDS subunit epsilon (cdhB) C 8.57E-21 1.75 3.36 
MA4392 
methyltransferase isozyme 1 
(mtaB2) 
C 0.0018 1.74 3.33 




S 4.40E-17 1.71 3.28 
MA1316 
Na+/proline symporter, proline 
permease (putP) 
E 1.81E-07 1.67 3.18 
MA4165 
methylcobalamin:CoM 
methyltransferase isozyme A (cmtA) 
C 3.91E-16 1.62 3.08 




M 0 1.58 3.00 
MA0505 hypothetical protein S 1.48E-11 1.56 2.95 
MA3861 ACDS subunit epsilon (cdhE) C 5.73E-07 1.56 2.95 
MA0620 histidine kinase & HK-like ATPase T 1.24E-10 1.51 2.86 
MA3862 ACDS subunit gamma (cdhC) C 3.77E-09 1.51 2.85 
MA2986 
Anthranilate/para-aminobenzoate 
synthase component II  
E 8.76E-04 1.49 2.82 
MA3864 ACDS subunit delta (cdhD) C 3.70E-23 1.49 2.81 
MA4166 sugar transport family protein G 7.42E-32 1.49 2.81 
MA1012 ACDS subunit delta (cdhD) C 2.32E-21 1.48 2.79 
MA3860 ACDS subunit alpha (cdhA) C 2.27E-08 1.48 2.79 
MA2990 
tryptophan synthase subunit alpha 
(trpA) 
E 0.0085 1.44 2.71 
MA0858 Hydantoinase (hyuA) E 1.47E-23 1.43 2.70 
MA4394 Zinc transporter R 0.0390 1.43 2.69 
MA3863 CO dehydrogenase accessory C 1.47E-16 1.42 2.68 
90 
protein  
MA2987 tryptophan synthase subunit epsilon E 0.0017 1.42 2.68 
MA1013 
CO dehydrogenase nickel-insertion 
accessory protein  
C 4.94E-18 1.41 2.66 
MA4385 hypothetical protein S 6.28E-04 1.41 2.66 
MA2991 
Tryptophan synthase beta 
superfamily 
E 0.0054 1.40 2.64 




S 5.61E-04 1.39 2.63 
MA3865 ACDS subunit epsilon (cdhE) C 5.46E-26 1.39 2.63 
MA4324 
Peptidase family M3B 
Oligopeptidase F (pepF) 




E 0.0110 1.38 2.59 
MA1011 ACDS subunit gamma (cdhC) C 9.69E-28 1.35 2.55 
MA4256 hypothetical protein S 0.0091 1.33 2.52 
MA1123 hypothetical protein S 4.05E-38 1.32 2.49 
MA2783 hypothetical protein S 2.91E-11 1.30 2.46 
MA4257 hypothetical protein S 0.0017 1.24 2.36 
MA3607 
Phosphate acetyltransferase 
involved in acetoclastic 
methanogenesis 
C 3.56E-11 1.23 2.35 
MA1102 
Formylglycine-generating enzyme 
required for sulfatase activity  
R 1.61E-35 1.23 2.34 
MA4017 Nicotianamine synthase protein R 7.04E-12 1.21 2.31 
MA4399 ACDS subunit alpha (cdhA) C 8.92E-09 1.20 2.30 
MA1418 ABC transport system for cobalt  P 8.79E-25 1.17 2.26 
MA4634 hypothetical protein S 5.56E-04 1.15 2.22 
MA2959 hypothetical protein S 1.97E-22 1.15 2.22 
MA1417 hypothetical protein S 1.48E-10 1.14 2.21 
MA3668 hypothetical protein S 3.36E-09 1.12 2.18 
MA2003 sodium-dependent transporter R 6.46E-20 1.11 2.16 
MA0345 hypothetical protein S 0.0031 1.10 2.14 
MA4365 ABC-2 family transporter protein,  R 2.92E-06 1.09 2.12 
MA0504 
ArsR family transcriptional 
regulator 
K 1.24E-09 1.08 2.12 
MA2244 coenzyme A ligase I 2.54E-06 1.06 2.08 
MA0203 signal-transducing histidine kinase T 9.31E-29 1.03 2.04 
MA3606 
Acetate kinase A invovled in 
acetoclastic methanogenesis 
C 2.68E-05 1.02 2.03 
MA1690 CrtC superfamily R 1.08E-05 1.02 2.03 
MA3198 
Tryptophan synthase subunit beta 
(trpB) 
E 6.67E-17 0.99 1.99 
MA2690 phosphoenolpyruvate carboxylase C 0.0204 0.98 1.97 
MA2272 ABC transporter, permease protein R 1.21E-10 0.98 1.97 
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MA1028 long-chain fatty-acid-CoA ligase I 9.69E-28 0.97 1.96 
MA3666 hypothetical protein S 3.99E-11 0.95 1.93 
MA1027 hypothetical protein S 9.85E-15 0.93 1.90 
MA0161 ferritin R 0.0059 0.93 1.90 




H 1.21E-08 0.92 1.90 
MA1553 hypothetical protein S 1.78E-14 0.92 1.90 
MA3667 hypothetical protein S 6.31E-09 0.90 1.87 
MA3665 hypothetical protein S 3.02E-07 0.88 1.84 
MA0162 universal stress protein R 0.0092 0.87 1.83 
MA2750 hypothetical protein S 1.17E-08 0.85 1.81 
MA0431 ferredoxin C 7.40E-07 0.84 1.78 
MA1550 hypothetical protein S 3.24E-05 0.83 1.78 
MA0533 hypothetical protein S 0.0091 0.81 1.75 
MA2324 hypothetical protein S 0.0077 0.80 1.75 
MA2945 hypothetical protein S 9.50E-09 0.80 1.74 
MA3121 hypothetical protein S 3.83E-15 0.79 1.73 
MA0163 hypothetical protein S 1.23E-04 0.79 1.73 
MA2453 hypothetical protein S 2.54E-06 0.79 1.73 
MA4475 hypothetical protein S 5.18E-05 0.77 1.70 
MA2273 hypothetical protein S 6.09E-16 0.76 1.69 





H 0.0217 0.74 1.67 
MA2021 hypothetical protein S 3.90E-07 0.74 1.67 
MA1463 
sensory transduction histidine 
kinase 
T 2.64E-04 0.74 1.67 
MA1953 hypothetical protein S 2.53E-06 0.73 1.66 
MA0945 hypothetical protein S 2.85E-05 0.73 1.66 
MA0556 hypothetical protein S 1.13E-09 0.72 1.65 
MA0092 hypothetical protein S 0.0271 0.71 1.64 
MA2964 hypothetical protein S 0.0385 0.71 1.64 
MA0107 gluconate 5-dehydrogenase R 2.08E-18 0.70 1.63 
MA4379 Methyltransferase isozyme 2 (mtaA) C 0.0016 0.70 1.62 
MA2275 
ABC transporter, ATP-binding 
protein 
R 7.95E-19 0.70 1.62 
MA4478 cell surface protein (slg) M 0.0094 0.69 1.62 
MA0425 hypothetical protein S 2.54E-07 0.69 1.61 
MA1545 hypothetical protein S 0.0137 0.67 1.59 
MA4562 hydantoinase (hyuA) E 0.0271 0.67 1.59 
MA0608 pyruvate phosphate dikinase (ppdK) G 2.93E-05 0.66 1.58 
MA1551 hypothetical protein S 7.57E-04 0.65 1.57 
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MA1542 hypothetical protein S 0.0021 0.64 1.56 
MA0857 hsp60-5 O 0.0062 0.64 1.56 
MA1725 phenylacetate-CoA ligase Q 8.24E-13 0.63 1.55 
MA2314 hypothetical protein S 0.0031 0.63 1.55 
MA0016 cheY2 T 3.56E-08 0.60 1.52 
MA2812 hypothetical protein S 0.0489 0.60 1.51 
MA3302 
Methanosarcina regulator of 
energy-converting metabolism 
(mreA) 
K 3.84E-04 0.59 1.51 
MA0707 caffeoyl-CoA O-methyltransferase E 3.67E-04 0.59 1.51 
MA0275 
tetrahydromethanopterin S-
methyltransferase, subunit D (mtrD) 
H 1.48E-10 0.59 1.50 
MA3443 hypothetical protein S 0.0055 0.59 1.50 
MA1500 
Fe420H2 dehydrogenase subunit 
(fpoI) 
C 0.0432 0.58 1.50 
MA1726 
indolepyruvate oxidoreductase, 
subunit beta (iorB) 
C 1.52E-14 0.58 1.49 
MA4036 
ABC transporter, ATP-binding 
protein 
R 3.35E-07 0.58 1.49 
MA0860 hypothetical protein S 1.21E-05 0.57 1.49 
MA1244 
oligopeptide ABC transporter, 
oligopeptide-binding protein 
R 0.0015 0.57 1.48 
MA2911 
2-oxoisovalerate ferredoxin 
oxidoreductase, gamma subunit 
C 6.72E-04 0.57 1.48 
MA0199 hypothetical protein S 6.39E-04 0.56 1.48 
MA0674 pyruvate carboxylase subunit B G 0.0021 0.56 1.47 
MA0273 
Tetrahydromethanopterin S-
methyltransferase, subunit beta 
H 1.93E-08 0.56 1.47 
MA1022 
indolepyruvate ferredoxin 
oxidoreductase, subunit alpha 
C 6.99E-05 0.55 1.47 
MA1660 hypothetical protein S 1.22E-06 0.54 1.45 
MA4386 hsp60-4 O 0.0020 0.53 1.45 
MA4028 hypothetical protein S 9.51E-04 0.53 1.44 
MA2406 transposase X 6.38E-04 0.53 1.44 
MA1536 
ABC transporter, ATP-binding 
protein 
R 1.78E-05 0.53 1.44 
MA1373 Fructose-1-phosphate kinase G 9.85E-10 0.53 1.44 
MA4349 
Branched-chain amino acid 
aminotransferase/4-amino-4-
deoxychorismate lyase 
E 7.73E-05 0.53 1.44 
MA3122 surface antigen gene M 0.0027 0.53 1.44 
MA4570 
multiple resistance/pH regulation 
related protein C (Na+/H+ 
antiporter) (mrpC) 
R 3.93E-04 0.53 1.44 





Coenzyme F420-dependent 5, 10-
methenyltetrahydromethanopterin 
dehydrogenase 
C 4.51E-04 0.52 1.43 
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MA4035 hypothetical protein S 0.0013 0.52 1.43 
MA1498 
F420H2 dehydrogenase subunit 
(fpoD) 
C 0.0054 0.51 1.43 
MA0693 hypothetical protein S 0.0345 0.51 1.43 
MA1653 integral membrane protein S 0.0134 0.51 1.43 
MA0675 
pyruvate carboxylase subunit A 
(pycA) 
G 0.0031 0.51 1.43 
MA0528 methyltransferase isozyme 1  C 0.0440 0.51 1.43 
MA4156 
F0F1-type ATP synthase, epsilon 
subunit 
C 0.0390 0.51 1.42 
MA3988 transposase X 0.0012 0.51 1.42 
MA2429 hypothetical protein S 1.48E-06 0.51 1.42 
MA0269 
Tetrahydromethanopterin S-
methyltransferase, subunit H (mtrH) 
H 4.13E-06 0.51 1.42 
MA2909 
2-oxoisovalerate ferredoxin 
oxidoreductase, alpha subunit 
(vorA) 
C 7.38E-04 0.50 1.42 
MA0980 hypothetical protein S 0.0265 0.50 1.42 
MA1248 ubiE/COQ5 methyltransferase H 3.05E-04 0.50 1.41 
MA4578 hypothetical protein S 2.03E-04 0.50 1.41 
MA1497 
F420H2 dehydrogenase subunit 
(fpoC) 
C 0.0061 0.49 1.41 




H 8.12E-07 0.49 1.40 
MA1400 hypothetical protein S 1.44E-08 0.49 1.40 
MA1877 hypothetical protein S 3.72E-04 0.49 1.40 
MA2890 
sensory transduction histidine 
kinase 
T 2.83E-12 0.49 1.40 
MA1495 F420H2 dehydrogenase subunit C 0.0190 0.49 1.40 
MA1698 hypothetical protein S 0.0425 0.48 1.40 
MA0560 hypothetical protein S 1.69E-06 0.48 1.39 
MA4159 
F0F1-type ATP synthase, subunit 
alpha (atpB) 
C 0.0245 0.48 1.39 
MA3369 hypothetical protein S 2.93E-05 0.47 1.39 
MA2106 hypothetical protein S 0.0156 0.47 1.39 
MA4611 hypothetical protein S 0.0356 0.47 1.39 
MA1940 hypothetical protein S 0.0053 0.47 1.38 
MA3293 hypothetical protein S 0.0031 0.46 1.38 
MA2630 alcohol dehydrogenase (adh) R 0.0123 0.46 1.38 
MA2238 hypothetical protein S 1.24E-08 0.46 1.38 
MA2912 AMP-binding protein R 3.93E-04 0.46 1.38 
MA4160 
F0F1-type ATP synthase, beta 
subunit 
C 0.0331 0.46 1.37 
MA2913 hypothetical protein S 0.0086 0.45 1.37 
MA1544 hypothetical protein S 0.0326 0.45 1.37 
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MA1249 
oligopeptide ABC transporter, 
oligopeptide-binding protein 
R 0.0053 0.45 1.37 




H 0.0074 0.45 1.36 
MA2656 hypothetical protein S 3.93E-05 0.44 1.36 
MA3728 hypothetical protein S 0.0178 0.44 1.36 
MA4566 
multiple resistance/pH regulation 
related protein G (Na+/H+ 
antiporter) (mrpG) 
R 0.0126 0.44 1.36 
MA0270 
Tetrahydromethanopterin S-
methyltransferase, subunit G 
H 2.52E-04 0.44 1.35 
MA3424 hypothetical protein S 9.21E-07 0.44 1.35 
MA2914 
Transcriptional regulator, Hth-3 
family 
K 2.12E-04 0.44 1.35 
MA2488 
ABC transporter, ATP-binding 
protein 




C 3.68E-05 0.44 1.35 
MA4152 
F0F1-type ATP synthase subunit 
(atpH) 
C 0.0158 0.43 1.35 
MA2478 
peptide ABC transporter, ATP-
binding protein 
R 0.0184 0.43 1.35 
MA0336 cell surface protein M 0.0036 0.43 1.35 
MA4477 hypothetical protein S 0.0075 0.43 1.35 
MA1590 surface antigen gene M 0.0208 0.43 1.35 
MA2497 Fumarate hydratase (fumA) C 9.95E-04 0.43 1.34 
MA3006 
Formaldehyde-activating enzyme in 
methanogenesis 
C 9.14E-04 0.42 1.34 
MA4476 hypothetical protein S 0.0027 0.42 1.34 
MA4380 hypothetical protein S 2.93E-05 0.42 1.33 
MA0831 transposase X 0.0286 0.41 1.33 
MA2536 Carbon anhydrase (cam) P 0.0012 0.41 1.33 
MA1483 Trk-type K+ transport system (trkH) P 1.85E-06 0.41 1.33 
MA0619 
sensory transduction histidine 
kinase 
T 6.38E-04 0.40 1.32 
MA1423 hypothetical protein S 0.0291 0.40 1.32 
MA1374 hypothetical protein S 3.30E-05 0.39 1.31 
MA2156 periplasmic binding protein R 4.17E-04 0.39 1.31 
MA1069 hypothetical protein S 0.0183 0.39 1.31 
MA1919 adenylosuccinate synthase F 6.12E-04 0.39 1.31 
MA1742 hypothetical protein S 0.0017 0.39 1.31 
MA1611 Leucyl-tRNA synthetase (leuS) J 0.0203 0.39 1.31 
MA2015 hypothetical protein S 0.0017 0.39 1.31 
MA0021 
high-affinity gluconate transporter 
(gluconate permease) 
G 0.0214 0.38 1.30 





E 0.0089 0.38 1.30 
MA3174 hypothetical protein S 0.0273 0.38 1.30 
MA0593 hypothetical protein S 0.0390 0.37 1.29 
MA1276 N-ethylammeline chlorohydrolase R 0.0405 0.36 1.28 
MA1543 hypothetical protein S 0.0091 0.36 1.28 
MA1055 hypothetical protein S 0.0333 0.35 1.27 
MA3437 
branched chain amino acid transport 
protein (azlC) 
E 3.73E-06 0.35 1.27 
MA1466 4-thiouridine synthase (thiI) J 0.0177 0.35 1.27 
MA1475 hypothetical protein S 0.0390 0.34 1.27 
MA3999 hypothetical protein S 0.0315 0.34 1.27 
MA2454 hypothetical protein S 3.55E-04 0.34 1.27 
MA1424 
transcriptional regulator, Hth-3 
family 
K 1.43E-04 0.34 1.26 
MA2582 hypothetical protein S 0.0332 0.34 1.26 
MA4237 Heterodisulfide reductase, subunit B C 0.0354 0.33 1.26 
MA2740 hypothetical protein S 0.0495 0.32 1.25 
MA2153 periplasmic binding protein R 0.0035 0.32 1.25 
MA2742 nitroreductase C 0.0135 0.32 1.25 
MA4154 
Corrinoid protein involved in 
methanogenesis (atpC) 
C 0.0299 0.32 1.25 
MA3791 Acetolactate synthase subunit (ilvH) E 2.39E-04 0.31 1.24 
MA1264 
DNA-directed RNA polymerase 
subunit B (rpoB1) 
K 0.0137 0.31 1.24 
MA1537 hypothetical protein S 0.0133 0.31 1.24 
MA3176 hypothetical protein S 0.0120 0.30 1.24 
MA3790 Ketol-acid reductoisomerase (ilvC) E 2.85E-04 0.30 1.23 
MA2115 hypothetical protein S 0.0164 0.30 1.23 
MA2553 
sensory transduction histidine 
kinase 
T 0.0160 0.30 1.23 
MA3175 hypothetical protein S 0.0390 0.29 1.23 
MA0561 hypothetical protein S 0.0340 0.29 1.22 
MA2431 Isoleucyl-tRNA synthetase (ileS) J 0.0239 0.29 1.22 
MA1274 
sensory transduction histidine 
kinase 
T 1.53E-04 0.29 1.22 
MA1031 hypothetical protein S 0.0069 0.29 1.22 
MA0777 signal-transducing histidine kinase T 0.0016 0.29 1.22 
MA4240 hypothetical protein S 0.0489 0.28 1.22 
MA1103 integral membrane protein R 7.85E-04 0.28 1.22 
MA1841 hypothetical protein S 0.0049 0.28 1.21 
MA1061 polysaccharide biosynthesis protein M 0.0484 0.27 1.21 
MA0003 sodium:proline symporter (putP) E 0.0275 0.27 1.20 
MA1263 
DNA-directed RNA polymerase 
subunit D (rpoA1) 
K 0.0141 0.26 1.20 
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MA1095 
Preprotein translocase subunit 
(secY) 
U 0.0037 0.25 1.19 
MA0558 hypothetical protein S 0.0498 0.24 1.18 
MA0750 hypothetical protein S 0.0340 0.23 1.17 
MA1096 Adenylate kinase (adk) F 0.0073 0.23 1.17 




F 0.0484 0.22 1.17 
MA0925 
aromatic amino acid transferase 
(tyrB) 
E 0.0132 0.22 1.16 
MA0916 
erythrocyte band 7 integral 
membrane protein 
R 0.0135 0.20 1.15 
MA1175 mannosyltransferase M 0.0349 0.20 1.15 




Table 11. Downregulated transcripts in Ma ΔmsvR 







MA1458 MaMsvR K 0 -12.57 -6070.85 
MA2425 Methyltransferase isozyme 1 (mtbB) C 5.21E-05 -3.31 -9.94 
MA3895 Nitrogenase subunit (nifH) P 0.0042 -3.16 -8.92 
MA2424 
Corrinoid protein involved in 
methanogenesis (mtbC) 
C 1.47E-12 -2.94 -7.65 
MA3471 hypothetical protein S 0.0190 -2.66 -6.32 
MA2288 hypothetical protein S 1.97E-10 -2.42 -5.34 
MA4207 ammonium transporter P 5.63E-06 -2.18 -4.52 




M 0 -1.91 -3.77 
MA0776 
hypothetical protein with TaqI-like 
C-terminal specificity domain 
R 3.61E-41 -1.85 -3.60 
MA4208 
P-II family nitrogen regulatory 
protein (glnB) 
E 2.39E-04 -1.85 -3.60 
MA1957 
sensory transduction histidine 
kinase 
T 8.62E-05 -1.82 -3.53 
MA1686 
3',5'-cyclic AMP phosphodiesterase 
(cpdA) 
T 5.34E-06 -1.81 -3.50 
MA4535 
hypothetical protein with 
methyltransferase domain 
R 6.76E-16 -1.72 -3.28 
MA4198 hypothetical protein S 4.25E-20 -1.66 -3.16 
MA4344 
efflux system transcriptional 
regulator, ArsR family (smtB) 
K 2.71E-04 -1.65 -3.13 
MA4340 biotin synthesis BioY protein H 2.58E-17 -1.56 -2.94 
MA4197 hypothetical protein S 3.74E-11 -1.54 -2.91 
MA3936 
Uncharacterized inner membrane 
protein YnfA 
R 0.0286 -1.54 -2.90 
MA1624 hypothetical protein S 8.81E-04 -1.53 -2.88 
MA4532 
iron compounds ABC transporter, 
ATP-binding protein 
P 1.95E-18 -1.52 -2.86 
MA4536 
ABC transporter, solute-binding 
protein 
R 7.35E-16 -1.50 -2.83 
MA2972 
Methyltransferase isozyme 1 
(mtmB2) 
C 0.0037 -1.48 -2.79 
MA2801 hypothetical protein S 2.82E-08 -1.44 -2.72 




R 1.04E-04 -1.35 -2.54 
MA4346 
hypothetical protein with PspC 
domain 
R 0.0031 -1.30 -2.46 
MA2355 hypothetical protein S 0.0024 -1.24 -2.36 
MA1214 
P-II family nitrogen regulatory 
protein (nifI1) 
P 3.83E-04 -1.23 -2.35 
MA4531 hypothetical protein with S-layer S 1.10E-05 -1.22 -2.32 
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family duplication domain 
MA1239 molybdenum-pterin binding protein R 8.24E-13 -1.19 -2.29 
MA1626 hypothetical protein S 0.0022 -1.14 -2.21 
MA2781 
hypothetical protein with 
methyltransferase domain 
R 0.0326 -1.12 -2.17 
MA2971 Corrinoid protein (mtmC) C 0.0248 -1.10 -2.15 
MA1234 
iron(III) ABC transporter, permease 
protein 
P 6.39E-04 -1.07 -2.10 
MA2267 hypothetical protein S 0.0017 -1.05 -2.07 
MA3240 hypothetical protein S 1.03E-17 -1.04 -2.06 
MA3044 SAM-dependent methyltransferase R 0.0315 -1.04 -2.06 
MA0546 hypothetical protein S 6.49E-07 -1.04 -2.06 
MA2802 hypothetical protein S 1.75E-04 -1.04 -2.05 
MA2803 hypothetical protein S 1.47E-05 -1.02 -2.03 
MA2974 hypothetical protein S 2.00E-04 -1.01 -2.02 
MA1200 
iron ABC transporter, solute-
binding protein 
R 0.0097 -0.97 -1.96 
MA4446 hypothetical protein S 4.49E-04 -0.94 -1.91 
MA3234 hypothetical protein S 0.03964 -0.93 -1.90 
MA4372 
hydrogenase-3, subunit E (HycE 
homolog) 
C 0.0188 -0.91 -1.87 




MA4216 Glutamine synthetase (glnA) E 4.39E-13 -0.88 -1.84 
MA1366 response regulator receiver T 5.77E-04 -0.86 -1.81 
MA0261 
Thiamine biosynthesis protein 
(thiC) 
H 1.62E-23 -0.82 -1.77 
MA4671 response regulator receiver T 0.0020 -0.80 -1.74 
MA4373 
hydrogenase-3, subunit G (HycG 
homolog) 
C 0.0343 -0.80 -1.74 
MA3046 
oligopeptide ABC transporter, 
oligopeptide-binding protein (oppD) 
R 5.26E-04 -0.80 -1.74 
MA4341 
Nickel and Cobalt transporter 
(cbiO) 
P 3.38E-18 -0.79 -1.73 
MA2804 hypothetical protein S 9.53E-05 -0.79 -1.73 
MA1212 
P-II family nitrogen regulatory 
protein (nifI1) 
P 0.0049 -0.77 -1.71 
MA0547 
winged HTH domain-containing 
protein/riboflavin kinase 
H 1.83E-04 -0.76 -1.70 
MA1271 hypothetical protein S 0.0019 -0.75 -1.68 
MA1211 
P-II family nitrogen regulatory 
protein (nifI2) 
P 2.44E-04 -0.74 -1.67 
MA2782 
TetR family transcriptional 
regulator 
K 0.0182 -0.73 -1.65 
MA4067 hypothetical protein S 1.87E-06 -0.72 -1.65 
MA4425 hypothetical protein S 0.0016 -0.72 -1.64 
MA2287 hypothetical protein S 0.0086 -0.70 -1.63 
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MA1233 
iron(III) ABC transporter, ATP-
binding protein 
R 0.0406 -0.70 -1.63 
MA4442 hypothetical protein S 0.0208 -0.67 -1.59 
MA0544 Protein-L-isoaspartate (pcm-1) O 6.86E-04 -0.67 -1.59 
MA1748 cobalt transport proteins (cbiQ) P 1.06E-05 -0.66 -1.58 
MA4058 hypothetical protein S 0.0190 -0.63 -1.54 




R 1.21E-10 -0.60 -1.52 
MA2657 hypothetical protein S 0.0183 -0.59 -1.50 
MA3943 hypothetical protein S 0.0438 -0.58 -1.50 
MA3664 cell surface protein R 0.0073 -0.57 -1.49 
MA1205 Nitrogenase subunit NifH (ATPase) P 0.0078 -0.56 -1.48 
MA0653 hypothetical protein S 0.0141 -0.56 -1.47 
MA3459 hypothetical protein S 0.0073 -0.55 -1.46 
MA4316 hypothetical protein S 0.0488 -0.54 -1.46 
MA0643 
H/ACA RNA-protein complex 
component Nop10p 
J 6.54E-09 -0.54 -1.46 
MA4465 hypothetical protein S 0.0272 -0.53 -1.45 
MA1740 hypothetical protein S 5.60E-04 -0.53 -1.44 
MA1210 
Nitrogenase iron-iron protein alpha 
chain (anfD) 
C 0.0039 -0.52 -1.44 
MA2188 transposase X 0.0073 -0.52 -1.44 
MA3632 Cadmium resistance protein (cadA) P 0.0327 -0.52 -1.43 
MA0303 hypothetical protein S 0.0129 -0.52 -1.43 
MA3852 transposase X 2.29E-04 -0.52 -1.43 
MA1290 transposase X 0.0076 -0.51 -1.42 
MA2748 transposase X 1.57E-04 -0.50 -1.41 
MA3529 transposase X 2.10E-04 -0.50 -1.41 
MA2815 GCN5-related N-acetyltransferase R 9.51E-04 -0.49 -1.40 
MA2204 hypothetical protein S 1.23E-04 -0.48 -1.39 
MA3166 hypothetical protein S 2.71E-04 -0.48 -1.39 
MA3550 hypothetical protein S 0.0025 -0.48 -1.39 
MA0513 maltose O-acetyltransferase (maa) G 9.35E-04 -0.47 -1.39 
MA2774 iron ABC transporter, permease R 0.0425 -0.47 -1.38 
MA2203 cellulosomal protein S 3.72E-07 -0.47 -1.38 
MA0644 
Translation initiation factor 2, alpha 
subunit (eIF-2A) 
J 1.74E-13 -0.46 -1.38 
MA4214 benzodiazepine receptor TspO R 0.0264 -0.46 -1.38 
MA0042 Peptide chain release factor (erf1) J 0.0023 -0.46 -1.37 
MA0424 hypothetical protein S 0.0017 -0.46 -1.37 
MA0812 hypothetical protein S 0.0305 -0.45 -1.37 
MA0519 hypothetical protein S 0.0477 -0.45 -1.37 
MA0646 Ribosomal protein L44E (rpl44e) J 2.02E-14 -0.45 -1.37 
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MA0265 hypothetical protein S 9.81E-04 -0.45 -1.37 
MA1977 
Molybdopterin-guanine 
dinucleotide biosynthesis protein A  
(mobA) 
H 0.0211 -0.45 -1.37 
MA1209 nitrogenase, subunit delta (anfG) C 0.0378 -0.45 -1.36 
MA1732 hypothetical protein S 0.0082 -0.44 -1.36 
MA2280 
ABC-type molybdate transport 
system, periplasmic component 
(modA) 
P 0.0326 -0.44 -1.35 
MA0703 hypothetical protein S 0.0059 -0.43 -1.35 
MA0642 3-isopropylmalate dehydratase E 2.49E-04 -0.43 -1.35 
MA0470 hypothetical protein S 0.0135 -0.43 -1.35 
MA0605 metallo-beta-lactamase R 0.0272 -0.43 -1.34 
MA1101 transcriptional regulator K 0.0317 -0.43 -1.34 
MA4440 polysaccharide deacetylase G 0.0451 -0.42 -1.34 
MA0543 Protein-L-isoaspartate (pcm-2) O 0.0135 -0.42 -1.34 
MA3291 hypothetical protein S 0.0078 -0.42 -1.34 
MA0302 
oligopeptide ABC transporter, 
oligopeptide-binding protein (oppA) 
R 0.0125 -0.42 -1.34 
MA0606 
bifunctional short chain isoprenyl 
diphosphate synthase (idsA) 
R 0.0477 -0.42 -1.34 
MA0763 hypothetical protein S 0.0104 -0.41 -1.33 
MA0462 hypothetical protein S 0.0297 -0.41 -1.33 
MA3904 ubiE/COQ5 methyltransferase R 0.0258 -0.41 -1.33 




F 0.0351 -0.40 -1.32 
MA3315 hypothetical protein S 0.0340 -0.39 -1.31 
MA0189 SNF2 family helicase K 0.0011 -0.39 -1.31 
MA0051 hypothetical protein S 0.0208 -0.38 -1.30 
MA0152 hypothetical protein S 0.0214 -0.37 -1.30 
MA2679 transposase X 0.0167 -0.37 -1.29 
MA4609 
DNA-(apurinic or apyrimidinic site) 
lyase 
L 0.0182 -0.37 -1.29 
MA3906 
oligopeptide ABC transporter, 
oligopeptide-binding protein (oppB) 
R 0.0186 -0.36 -1.29 
MA2816 GCN5-related N-acetyltransferase R 0.0191 -0.36 -1.28 
MA4195 Fe-S oxidoreductase family (nifB) C 0.0337 -0.36 -1.28 
MA1961 
cell surface glycoprotein (S-layer 
protein) 
M 0.0031 -0.35 -1.28 
MA1363 phosphoglycolate phosphatase R 2.29E-04 -0.35 -1.28 
MA4060 hypothetical protein S 0.0137 -0.35 -1.28 
MA0008 Pheromone shutdown protein (traB) S 0.0073 -0.34 -1.27 
MA4424 hypothetical protein S 0.0132 -0.34 -1.27 
MA0757 phosphoesterase R 0.0031 -0.34 -1.27 
MA3021 sodium/calcium exchanger protein R 2.82E-04 -0.34 -1.27 
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MA0747 hypothetical protein S 0.0072 -0.34 -1.26 
MA1915 D-aminopeptidase (dppA) E 0.0494 -0.34 -1.26 
MA0909 ATPase R 0.0378 -0.34 -1.26 
MA1741 ribosomal biogenesis protein J 0.0020 -0.34 -1.26 
MA0645 Ribosomal protein S27E (rps27e) J 8.45E-04 -0.34 -1.26 
MA2609 hypothetical protein S 0.0390 -0.34 -1.26 
MA0452 glycosyltransferase M 0.0018 -0.33 -1.26 
MA0803 hypothetical protein S 0.0015 -0.33 -1.25 
MA4615 
Isopropylmalate/homocitrate/citram
alate synthase (leuA) 
E 0.0019 -0.33 -1.25 
MA3378 hypothetical protein S 0.0042 -0.32 -1.25 
MA0866 hypothetical protein S 0.0166 -0.32 -1.25 
MA3338 hypothetical protein S 0.0259 -0.32 -1.25 
MA1949 glutamate decarboxylase E 0.0273 -0.31 -1.24 
MA2628 
glycogen debranching enzyme 
(GDB1) 
G 0.0075 -0.31 -1.24 
MA1310 hypothetical protein S 7.38E-04 -0.30 -1.23 
MA1645 
sensory transduction histidine 
kinase 
T 5.57E-04 -0.29 -1.23 
MA1026 hypothetical protein S 0.0276 -0.29 -1.23 
MA0030 hypothetical protein S 0.0349 -0.29 -1.22 
MA0684 
Flavodoxin reductase (ferredoxin-
NADPH reductase) family 1 (fprB) 
C 0.0469 -0.29 -1.22 
MA2259 hypothetical protein S 0.0408 -0.29 -1.22 
MA1425 transposase X 0.0349 -0.28 -1.22 
MA2163 
Methyltransferase isozyme 2 
involved in methanogenesis (ctmM) 
C 0.0089 -0.28 -1.22 
MA0120 hypothetical protein S 8.58E-04 -0.28 -1.21 
MA0210 hypothetical protein S 0.0477 -0.27 -1.21 
MA4317 
phycocyanin alpha phycocyanobilin 
lyase related protein 
R 0.0188 -0.27 -1.20 
MA3853 Cell division ATPase (ftsA) D 0.0471 -0.27 -1.20 
MA4111 Ribosomal protein L24 (rplX) J 0.0045 -0.26 -1.20 
MA1352 hypothetical protein S 0.0331 -0.25 -1.19 
MA4507 
Superfamily II DNA helicase 
(RecQ) 
L 0.0117 -0.25 -1.19 
MA4020 
ABC transporter, ATP-binding 
protein 
R 0.0027 -0.25 -1.19 
MA4573 hypothetical protein S 0.0059 -0.25 -1.19 
MA3975 type IV secretion system protein R 0.0018 -0.25 -1.19 
MA0720 hypothetical protein S 0.0193 -0.24 -1.18 




G 0.0289 -0.23 -1.18 
MA0081 Polyphosphate kinase (ppk) P 0.0270 -0.23 -1.17 
MA4475 Dihydrodipicolinate synthase/N- E 0.0020 -0.22 -1.17 
102 
acetylneuraminate lyase (dapA) 
MA4376 response regulator receiver T 0.0080 -0.21 -1.16 
MA2968 hypothetical protein S 0.0180 -0.20 -1.15 
MA4114 Ribosomal protein L39E (rpl39e) J 0.0400 -0.19 -1.14 
MA4110 prefoldin, subunit alpha (pfdA) O 0.0474 -0.18 -1.14 
 
